CN114437134A - Luminescent material with polycyclic ligand - Google Patents

Luminescent material with polycyclic ligand Download PDF

Info

Publication number
CN114437134A
CN114437134A CN202110348602.6A CN202110348602A CN114437134A CN 114437134 A CN114437134 A CN 114437134A CN 202110348602 A CN202110348602 A CN 202110348602A CN 114437134 A CN114437134 A CN 114437134A
Authority
CN
China
Prior art keywords
carbon atoms
substituted
groups
unsubstituted
group
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN202110348602.6A
Other languages
Chinese (zh)
Inventor
张翠芳
张奇
路楠楠
代志洪
邝志远
夏传军
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Beijing Summer Sprout Technology Co Ltd
Original Assignee
Beijing Summer Sprout Technology Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Beijing Summer Sprout Technology Co Ltd filed Critical Beijing Summer Sprout Technology Co Ltd
Priority to US17/241,836 priority Critical patent/US20220109118A1/en
Priority to DE102021110753.9A priority patent/DE102021110753B4/en
Priority to JP2021076326A priority patent/JP7278631B2/en
Priority to KR1020210055624A priority patent/KR102652631B1/en
Publication of CN114437134A publication Critical patent/CN114437134A/en
Priority to US17/979,546 priority patent/US20230144101A1/en
Priority to JP2023072357A priority patent/JP2023090828A/en
Priority to KR1020240039587A priority patent/KR20240041899A/en
Pending legal-status Critical Current

Links

Images

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F15/00Compounds containing elements of Groups 8, 9, 10 or 18 of the Periodic Table
    • C07F15/0006Compounds containing elements of Groups 8, 9, 10 or 18 of the Periodic Table compounds of the platinum group
    • C07F15/0033Iridium compounds
    • CCHEMISTRY; METALLURGY
    • C09DYES; PAINTS; POLISHES; NATURAL RESINS; ADHESIVES; COMPOSITIONS NOT OTHERWISE PROVIDED FOR; APPLICATIONS OF MATERIALS NOT OTHERWISE PROVIDED FOR
    • C09KMATERIALS FOR MISCELLANEOUS APPLICATIONS, NOT PROVIDED FOR ELSEWHERE
    • C09K11/00Luminescent, e.g. electroluminescent, chemiluminescent materials
    • C09K11/06Luminescent, e.g. electroluminescent, chemiluminescent materials containing organic luminescent materials
    • HELECTRICITY
    • H10SEMICONDUCTOR DEVICES; ELECTRIC SOLID-STATE DEVICES NOT OTHERWISE PROVIDED FOR
    • H10KORGANIC ELECTRIC SOLID-STATE DEVICES
    • H10K85/00Organic materials used in the body or electrodes of devices covered by this subclass
    • H10K85/30Coordination compounds
    • H10K85/341Transition metal complexes, e.g. Ru(II)polypyridine complexes
    • H10K85/342Transition metal complexes, e.g. Ru(II)polypyridine complexes comprising iridium
    • CCHEMISTRY; METALLURGY
    • C09DYES; PAINTS; POLISHES; NATURAL RESINS; ADHESIVES; COMPOSITIONS NOT OTHERWISE PROVIDED FOR; APPLICATIONS OF MATERIALS NOT OTHERWISE PROVIDED FOR
    • C09KMATERIALS FOR MISCELLANEOUS APPLICATIONS, NOT PROVIDED FOR ELSEWHERE
    • C09K2211/00Chemical nature of organic luminescent or tenebrescent compounds
    • C09K2211/10Non-macromolecular compounds
    • C09K2211/1018Heterocyclic compounds
    • C09K2211/1025Heterocyclic compounds characterised by ligands
    • C09K2211/1029Heterocyclic compounds characterised by ligands containing one nitrogen atom as the heteroatom
    • C09K2211/1033Heterocyclic compounds characterised by ligands containing one nitrogen atom as the heteroatom with oxygen
    • CCHEMISTRY; METALLURGY
    • C09DYES; PAINTS; POLISHES; NATURAL RESINS; ADHESIVES; COMPOSITIONS NOT OTHERWISE PROVIDED FOR; APPLICATIONS OF MATERIALS NOT OTHERWISE PROVIDED FOR
    • C09KMATERIALS FOR MISCELLANEOUS APPLICATIONS, NOT PROVIDED FOR ELSEWHERE
    • C09K2211/00Chemical nature of organic luminescent or tenebrescent compounds
    • C09K2211/10Non-macromolecular compounds
    • C09K2211/1018Heterocyclic compounds
    • C09K2211/1025Heterocyclic compounds characterised by ligands
    • C09K2211/1044Heterocyclic compounds characterised by ligands containing two nitrogen atoms as heteroatoms
    • C09K2211/1048Heterocyclic compounds characterised by ligands containing two nitrogen atoms as heteroatoms with oxygen
    • CCHEMISTRY; METALLURGY
    • C09DYES; PAINTS; POLISHES; NATURAL RESINS; ADHESIVES; COMPOSITIONS NOT OTHERWISE PROVIDED FOR; APPLICATIONS OF MATERIALS NOT OTHERWISE PROVIDED FOR
    • C09KMATERIALS FOR MISCELLANEOUS APPLICATIONS, NOT PROVIDED FOR ELSEWHERE
    • C09K2211/00Chemical nature of organic luminescent or tenebrescent compounds
    • C09K2211/18Metal complexes
    • C09K2211/185Metal complexes of the platinum group, i.e. Os, Ir, Pt, Ru, Rh or Pd

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Materials Engineering (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Inorganic Chemistry (AREA)
  • Electroluminescent Light Sources (AREA)

Abstract

A luminescent material having a polycyclic ligand is disclosed. The luminescent material is a metal complex with polycyclic ligands, and can be used as a luminescent material in an electroluminescent device. The novel metal complexes can better adjust the luminous color of the device while keeping very narrow half-peak width, reduce the driving voltage of the device or keep low voltage level, improve the efficiency of the device, greatly improve the service life of the device and provide better device performance. An electroluminescent device and compound combinations are also disclosed.

Description

Luminescent material with polycyclic ligand
Technical Field
The present invention relates to compounds for use in organic electronic devices, such as organic light emitting devices. More particularly, it relates to a metal complex having a polycyclic ligand, and an electroluminescent device and compound combination comprising the metal complex.
Background
Organic electronic devices include, but are not limited to, the following classes: organic Light Emitting Diodes (OLEDs), organic field effect transistors (O-FETs), Organic Light Emitting Transistors (OLETs), Organic Photovoltaics (OPVs), dye-sensitized solar cells (DSSCs), organic optical detectors, organic photoreceptors, organic field effect devices (OFQDs), light emitting electrochemical cells (LECs), organic laser diodes, and organic plasma light emitting devices.
In 1987, Tang and Van Slyke of Islamic Kodak reported a two-layer organic electroluminescent device comprising an arylamine hole transport layer and a tris-8-hydroxyquinoline-aluminum layer as an electron transport layer and a light-emitting layer (Applied Physics Letters, 1987,51(12): 913-915). Upon biasing the device, green light is emitted from the device. The invention lays a foundation for the development of modern Organic Light Emitting Diodes (OLEDs). The most advanced OLEDs may comprise multiple layers, such as charge injection and transport layers, charge and exciton blocking layers, and one or more light emitting layers between the cathode and anode. Since OLEDs are a self-emissive solid state device, it offers great potential for display and lighting applications. Furthermore, the inherent properties of organic materials, such as their flexibility, may make them well suited for particular applications, such as in the fabrication of flexible substrates.
OLEDs can be classified into three different types according to their light emitting mechanisms. The OLEDs of the invention by Tang and van Slyke are fluorescent OLEDs. It uses only singlet luminescence. The triplet states generated in the device are wasted through the non-radiative decay channel. Therefore, the Internal Quantum Efficiency (IQE) of fluorescent OLEDs is only 25%. This limitation hinders the commercialization of OLEDs. In 1997, Forrest and Thompson reported phosphorescent OLEDs, which use triplet emission from complex-containing heavy metals as emitters. Thus, singlet and triplet states can be harvested, achieving 100% IQE. Due to its high efficiency, the discovery and development of phosphorescent OLEDs directly contributes to the commercialization of active matrix OLEDs (amoleds). Recently, Adachi has achieved high efficiency through Thermally Activated Delayed Fluorescence (TADF) of organic compounds. These emitters have a small singlet-triplet gap, making it possible for excitons to return from the triplet state to the singlet state. In TADF devices, triplet excitons are able to generate singlet excitons through reverse intersystem crossing, resulting in high IQE.
OLEDs can also be classified into small molecule and polymer OLEDs depending on the form of the material used. Small molecule refers to any organic or organometallic material that is not a polymer. The molecular weight of small molecules can be large, as long as they have a precise structure. Dendrimers with well-defined structures are considered small molecules. The polymeric OLED comprises a conjugated polymer and a non-conjugated polymer having a pendant light-emitting group. Small molecule OLEDs can become polymer OLEDs if post-polymerization occurs during the fabrication process.
Various OLED manufacturing methods exist. Small molecule OLEDs are typically fabricated by vacuum thermal evaporation. Polymer OLEDs are fabricated by solution processes such as spin coating, ink jet printing and nozzle printing. Small molecule OLEDs can also be made by solution processes if the material can be dissolved or dispersed in a solvent.
The light emitting color of the OLED can be realized by the structural design of the light emitting material. An OLED may comprise one light emitting layer or a plurality of light emitting layers to achieve a desired spectrum. Green, yellow and red OLEDs, phosphorescent materials have been successfully commercialized. Blue phosphorescent devices still have the problems of blue unsaturation, short device lifetime, high operating voltage, and the like. Commercial full-color OLED displays typically employ a hybrid strategy using either blue fluorescent and phosphorescent yellow, or red and green. At present, the rapid decrease in efficiency of phosphorescent OLEDs at high luminance is still a problem. In addition, it is desirable to have a more saturated emission spectrum, higher efficiency and longer device lifetime.
The phosphorescent metal complex can be used as a phosphorescent doping material of a light-emitting layer and applied to the field of organic electroluminescent lighting or display.
In CN110698518A discloses
Figure BDA0003001663800000011
A metal complex of the structure wherein X is N or P, one of the structures in the plurality of structures disclosed being:
Figure BDA0003001663800000021
the inventors have investigated the improvement in properties brought about by the N, P atom bridging to the material, but have not noted the improvement in properties brought about by the reintroduction of a fused ring system at a specific position on a specific ring.
In CN110790797A discloses
Figure BDA0003001663800000022
A metal complex of the structure, one of which in the plurality of structures disclosed is:
Figure BDA0003001663800000023
the inventors have investigated the improvement in properties brought about by the O, S atom bridging to the material, but have not noted the improvement in properties brought about by the reintroduction of a fused ring system at a specific position on a specific ring.
The performance of the metal complexes developed so far in the electroluminescent device still has various defects. In order to meet the increasing demands of the industry, such as lower voltage, higher device efficiency, light emission color in a specific wavelength range, more saturated light emission color, and longer device lifetime, research and development on metal complexes are still urgently needed.
Disclosure of Invention
The present invention aims to solve at least part of the above problems by providing a series of metal complexes with polycyclic ligands. The metal complex can be used as a luminescent material in an organic electroluminescent device. The novel metal complexes can better adjust the luminous color of the device while keeping very narrow half-peak width, reduce the driving voltage of the device or keep low voltage level, improve the efficiency of the device and greatly improve the service life of the device. The novel metal complexes can provide better device performance.
According to one embodiment of the present invention, a metal complex is disclosed comprising a ligand La,LaHas a structure represented by formula 1:
Figure BDA0003001663800000024
wherein, ring A and ring B are each independently selected from five-membered unsaturated carbocyclic ring, aromatic ring with 6-30 carbon atoms or heteroaromatic ring with 3-30 carbon atoms;
Rithe same or different at each occurrence represents mono-, poly-, or no substitution; riiThe same or different at each occurrence represents mono-, poly-, or no substitution;
y is selected from SiRyRy,GeRyRy,NRy,PRyO, S or Se;
when two R are simultaneously presentyWhen two R are presentyMay be the same or different;
X1-X2selected from CR, identically or differently at each occurrencexOr N;
R、Ri、Rii、Rxand RyEach occurrence, the same or different, is selected from the group consisting of: hydrogen, deuterium, halogen, substituted or unsubstituted alkyl having 1 to 20 carbon atoms, substituted or unsubstituted cycloalkyl having 3 to 20 ring carbon atoms, substituted or unsubstituted heteroalkyl having 1 to 20 carbon atoms, substituted or unsubstituted aralkyl having 7 to 30 carbon atoms, substituted or unsubstituted alkoxy having 1 to 20 carbon atoms, substituted or unsubstituted aryloxy having 6 to 30 carbon atomsA group, a substituted or unsubstituted alkenyl group having 2 to 20 carbon atoms, a substituted or unsubstituted aryl group having 6 to 30 carbon atoms, a substituted or unsubstituted heteroaryl group having 3 to 30 carbon atoms, a substituted or unsubstituted alkylsilyl group having 3 to 20 carbon atoms, a substituted or unsubstituted arylsilyl group having 6 to 20 carbon atoms, a substituted or unsubstituted amine group having 0 to 20 carbon atoms, an acyl group, a carbonyl group, a carboxylic acid group, an ester group, a cyano group, an isocyano group, a mercapto group, a sulfinyl group, a sulfonyl group, a phosphino group, and combinations thereof;
adjacent substituents Ri、Rx、RyR and RiiCan optionally be linked to form a ring;
the metal is selected from metals having a relative atomic mass greater than 40.
According to another embodiment of the present invention, there is also disclosed an electroluminescent device comprising an anode, a cathode, and an organic layer disposed between the anode and the cathode, the organic layer comprising a metal complex comprising a ligand La,LaHas a structure represented by formula 1:
Figure BDA0003001663800000031
wherein, ring A and ring B are each independently selected from five-membered unsaturated carbocyclic ring, aromatic ring with 6-30 carbon atoms or heteroaromatic ring with 3-30 carbon atoms;
Rithe same or different at each occurrence represents mono-, poly-, or no substitution; riiThe same or different at each occurrence indicates mono-, poly-, or no substitution;
y is selected from SiRyRy,GeRyRy,NRy,PRyO, S or Se;
when two R are simultaneously presentyWhen two R are presentyMay be the same or different;
X1-X2selected from CR, identically or differently at each occurrencexOr N;
R、Ri、Rii、Rxand RyEach occurrence, the same or different, is selected from the group consisting of: hydrogen, deuterium, halogen, substituted or unsubstituted alkyl groups having 1 to 20 carbon atoms, substituted or unsubstituted cycloalkyl groups having 3 to 20 ring carbon atoms, substituted or unsubstituted heteroalkyl groups having 1 to 20 carbon atoms, substituted or unsubstituted aralkyl groups having 7 to 30 carbon atoms, substituted or unsubstituted alkoxy groups having 1 to 20 carbon atoms, substituted or unsubstituted aryloxy groups having 6 to 30 carbon atoms, substituted or unsubstituted alkenyl groups having 2 to 20 carbon atoms, substituted or unsubstituted aryl groups having 6 to 30 carbon atoms, substituted or unsubstituted heteroaryl groups having 3 to 30 carbon atoms, substituted or unsubstituted alkylsilyl groups having 3 to 20 carbon atoms, substituted or unsubstituted arylsilyl groups having 6 to 20 carbon atoms, substituted or unsubstituted amine groups having 0-20 carbon atoms, acyl groups, carbonyl groups, carboxylic acid groups, ester groups, cyano groups, isocyano groups, mercapto groups, sulfinyl groups, sulfonyl groups, phosphino groups, and combinations thereof;
adjacent substituents Ri、Rx、RyR and RiiCan optionally be linked to form a ring;
the metal is selected from metals having a relative atomic mass greater than 40.
According to another embodiment of the present invention, a combination of compounds is also disclosed, comprising the metal complex of the above embodiment.
The novel metal complex with polycyclic ligand disclosed by the invention can be used as a luminescent material in an electroluminescent device. The novel metal complexes can better adjust the luminous color of the device while keeping very narrow half-peak width, reduce the driving voltage of the device or keep low voltage level, improve the efficiency of the device and greatly improve the service life of the device. The novel metal complexes can provide better device performance.
Drawings
FIG. 1 is a schematic representation of an organic light emitting device that can contain the metal complexes and compound combinations disclosed herein.
FIG. 2 is a schematic representation of another organic light emitting device that may contain combinations of the metal complexes and compounds disclosed herein.
FIG. 3 is a ligand L displaying a metal complex as disclosed hereinaThe structural formula 1.
Detailed Description
OLEDs can be fabricated on a variety of substrates, such as glass, plastic, and metal. Fig. 1 schematically, but without limitation, illustrates an organic light emitting device 100. The figures are not necessarily to scale, and some of the layer structures in the figures may be omitted as desired. The device 100 may include a substrate 101, an anode 110, a hole injection layer 120, a hole transport layer 130, an electron blocking layer 140, an emissive layer 150, a hole blocking layer 160, an electron transport layer 170, an electron injection layer 180, and a cathode 190. The device 100 may be fabricated by sequentially depositing the described layers. The nature and function of the layers, as well as exemplary materials, are described in more detail in U.S. patent US7,279,704B2, columns 6-10, which is incorporated herein by reference in its entirety.
There are more instances of each of these layers. For example, a flexible and transparent substrate-anode combination is disclosed in U.S. Pat. No. 5,844,363, which is incorporated by reference in its entirety. An example of a p-doped hole transport layer is doped with F at a molar ratio of 50:14TCNQ m-MTDATA as disclosed in U.S. patent application publication No. 2003/0230980, which is incorporated by reference in its entirety. Examples of host materials are disclosed in U.S. patent No. 6,303,238 to Thompson et al, which is incorporated by reference in its entirety. An example of an n-doped electron transport layer is BPhen doped with Li at a molar ratio of 1:1, as disclosed in U.S. patent application publication No. 2003/0230980, which is incorporated by reference in its entirety. U.S. Pat. Nos. 5,703,436 and 5,707,745, which are incorporated by reference in their entirety, disclose examples of cathodes including composite cathodes having a thin layer of a metal such as Mg: Ag and an overlying layer of transparent, conductive, sputter-deposited ITO. The principles and use of barrier layers are described in more detail in U.S. patent No. 6,097,147 and U.S. patent application publication No. 2003/0230980, which are incorporated by reference in their entirety. By way of full referenceExamples of injection layers are provided in incorporated U.S. patent application publication No. 2004/0174116. A description of a protective layer may be found in U.S. patent application publication No. 2004/0174116, which is incorporated by reference in its entirety.
The above-described hierarchical structure is provided via non-limiting embodiments. The function of the OLED may be achieved by combining the various layers described above, or some layers may be omitted entirely. It may also include other layers not explicitly described. Within each layer, a single material or a mixture of materials may be used to achieve optimal performance. Any functional layer may comprise several sub-layers. For example, the light emitting layer may have two layers of different light emitting materials to achieve a desired light emission spectrum.
In one embodiment, an OLED may be described as having an "organic layer" disposed between a cathode and an anode. The organic layer may include one or more layers.
The OLED also requires an encapsulation layer, as shown in fig. 2, which is an exemplary, non-limiting illustration of an organic light emitting device 200, which differs from fig. 1 in that an encapsulation layer 102 may also be included over the cathode 190 to protect against harmful substances from the environment, such as moisture and oxygen. Any material capable of providing an encapsulation function may be used as the encapsulation layer, such as glass or a hybrid organic-inorganic layer. The encapsulation layer should be placed directly or indirectly outside the OLED device. Multilayer film encapsulation is described in U.S. patent US7,968,146B2, the entire contents of which are incorporated herein by reference.
Devices manufactured according to embodiments of the present invention may be incorporated into various consumer products having one or more electronic component modules (or units) of the device. Some examples of such consumer products include flat panel displays, monitors, medical monitors, televisions, billboards, lights for indoor or outdoor lighting and/or signaling, head-up displays, fully or partially transparent displays, flexible displays, smart phones, tablet computers, tablet handsets, wearable devices, smart watches, laptop computers, digital cameras, camcorders, viewfinders, micro-displays, 3-D displays, vehicle displays, and tail lights.
The materials and structures described herein may also be used in other organic electronic devices as previously listed.
As used herein, "top" means furthest from the substrate, and "bottom" means closest to the substrate. Where a first layer is described as being "disposed on" a second layer, the first layer is disposed farther from the substrate. Other layers may be present between the first and second layers, unless it is specified that the first layer is "in contact with" the second layer. For example, a cathode can be described as being "disposed on" an anode even though various organic layers are present between the cathode and the anode.
As used herein, "solution processable" means capable of being dissolved, dispersed or transported in and/or deposited from a liquid medium in the form of a solution or suspension.
A ligand may be referred to as "photoactive" when it is believed that the ligand directly contributes to the photoactive properties of the emissive material. A ligand may be referred to as "ancillary" when it is believed that the ligand does not contribute to the photoactive properties of the emissive material, but that the ancillary ligand may alter the properties of the photoactive ligand.
It is believed that the Internal Quantum Efficiency (IQE) of fluorescent OLEDs can be limited by delaying fluorescence beyond 25% spin statistics. Delayed fluorescence can generally be divided into two types, i.e., P-type delayed fluorescence and E-type delayed fluorescence. P-type delayed fluorescence results from triplet-triplet annihilation (TTA).
On the other hand, E-type delayed fluorescence does not depend on collision of two triplet states, but on conversion between a triplet state and a singlet excited state. Compounds capable of producing E-type delayed fluorescence need to have a very small mono-triplet gap in order to switch between energy states. Thermal energy can activate the transition from the triplet state back to the singlet state. This type of delayed fluorescence is also known as Thermally Activated Delayed Fluorescence (TADF). A significant feature of TADF is that the retardation component increases with increasing temperature. If the reverse intersystem crossing (RISC) rate is fast enough to minimize non-radiative decay from the triplet state, then the fraction of backfill singlet excited states may reach 75%. The total singlet fraction may be 100%, well in excess of 25% of the spin statistics of the electrogenerated excitons.
The delayed fluorescence characteristic of type E can be found in excited complex systems or in single compounds. Without being bound by theory, it is believed that E-type delayed fluorescence requires the light emitting material to have a small mono-triplet energy gap (Δ Ε)S-T). Organic non-metal containing donor-acceptor emissive materials may be able to achieve this. The emission of these materials is generally characterized as donor-acceptor Charge Transfer (CT) type emission. Spatial separation of HOMO from LUMO in these donor-acceptor type compounds generally results in small Δ ES-T. These states may include CT states. Generally, donor-acceptor light emitting materials are constructed by linking an electron donor moiety (e.g., an amino or carbazole derivative) to an electron acceptor moiety (e.g., a six-membered, N-containing, aromatic ring).
Definitions for substituent terms
Halogen or halide-as used herein, includes fluorine, chlorine, bromine and iodine.
Alkyl-comprises both straight and branched chain alkyl groups. The alkyl group may be an alkyl group having 1 to 20 carbon atoms, preferably an alkyl group having 1 to 12 carbon atoms, more preferably an alkyl group having 1 to 6 carbon atoms. Examples of alkyl groups include methyl, ethyl, propyl, isopropyl, n-butyl, sec-butyl, isobutyl, tert-butyl, n-pentyl, n-hexyl, n-heptyl, n-octyl, n-nonyl, n-decyl, n-undecyl, n-dodecyl, n-tridecyl, n-tetradecyl, n-pentadecyl, n-hexadecyl, n-heptadecyl, n-octadecyl, neopentyl, 1-methylpentyl, 2-methylpentyl, 1-pentylhexyl, 1-butylpentyl, 1-heptyloctyl, 3-methylpentyl. In addition, the alkyl group may be optionally substituted. The carbons in the alkyl chain may be substituted with other heteroatoms. Among the above, methyl, ethyl, propyl, isopropyl, n-butyl, sec-butyl, isobutyl, tert-butyl, n-pentyl and neopentyl are preferable.
Cycloalkyl-as used herein, comprises a cyclic alkyl group. Preferred cycloalkyl groups are those containing 4 to 10 ring carbon atoms and include cyclobutyl, cyclopentyl, cyclohexyl, 4-methylcyclohexyl, 4, 4-dimethylcyclohexyl, 1-adamantyl, 2-adamantyl, 1-norbornyl, 2-norbornyl and the like. In addition, the cycloalkyl group may be optionally substituted. The carbon in the ring may be substituted with other heteroatoms.
Alkenyl-as used herein, encompasses both straight and branched chain olefinic groups. Preferred alkenyl groups are those containing 2 to 15 carbon atoms. Examples of the alkenyl group include a vinyl group, an allyl group, a 1-butenyl group, a 2-butenyl group, a 3-butenyl group, a1, 3-butadienyl group, a 1-methylvinyl group, a styryl group, a 2, 2-diphenylvinyl group, a 1-methylallyl group, a1, 1-dimethylallyl group, a 2-methylallyl group, a 1-phenylallyl group, a 3, 3-diphenylallyl group, a1, 2-dimethylallyl group, a 1-phenyl-1-butenyl group and a 3-phenyl-1-butenyl group. In addition, alkenyl groups may be optionally substituted.
Alkynyl-as used herein, straight and branched alkynyl groups are contemplated. Preferred alkynyl groups are those containing 2 to 15 carbon atoms. In addition, alkynyl groups may be optionally substituted.
Aryl or aromatic-as used herein, non-fused and fused systems are contemplated. Preferred aryl groups are those containing from 6 to 60 carbon atoms, more preferably from 6 to 20 carbon atoms, and even more preferably from 6 to 12 carbon atoms. Examples of aryl groups include phenyl, biphenyl, terphenyl, triphenylene, tetraphenylene, naphthalene, anthracene, phenalene, phenanthrene, fluorene, pyrene,
Figure BDA0003001663800000061
perylene and azulene, preferably phenyl, biphenyl, terphenyl, triphenylene, fluorene and naphthalene. In addition, the aryl group may be optionally substituted. Examples of non-fused aryl groups include phenyl, biphenyl-2-yl, biphenyl-3-yl, biphenyl-4-yl, p-terphenyl-4-yl, p-terphenyl-3-yl, p-terphenyl-2-yl, m-terphenyl-4-yl, m-terphenyl-3-yl, m-terphenyl-2-yl, o-tolyl, m-tolyl, p-tolyl, p- (2-phenylpropyl) phenyl, 4 '-methyldiphenyl, 4' -tert-butyl-p-terphenyl-4-yl, o-cumyl, m-cumyl, p-cumyl, 2, 3-xylyl, 3, 4-xylyl, 2, 5-xylyl, mesityl and m-quaterphenyl.
Heterocyclyl or heterocyclic-as used herein, aromatic and non-aromatic cyclic groups are contemplated. Heteroaryl also refers to heteroaryl. Preferred non-aromatic heterocyclic groups are those containing 3 to 7 ring atoms, which include at least one heteroatom such as nitrogen, oxygen and sulfur. The heterocyclic group may also be an aromatic heterocyclic group having at least one hetero atom selected from a nitrogen atom, an oxygen atom, a sulfur atom and a selenium atom.
Heteroaryl-as used herein, non-fused and fused heteroaromatic groups are contemplated which may contain 1 to 5 heteroatoms. Preferred heteroaryl groups are those containing from 3 to 30 carbon atoms, more preferably from 3 to 20 carbon atoms, more preferably from 3 to 12 carbon atoms. Suitable heteroaryl groups include dibenzothiophene, dibenzofuran, dibenzoselenophene, furan, thiophene, benzofuran, benzothiophene, benzoselenophene, carbazole, indolocarbazole, pyridine indole, pyrrolopyridine, pyrazole, imidazole, triazole, oxazole, thiazole, oxadiazole, bisoxazole, thiadiazole, pyridine, pyridazine, pyrimidine, pyrazine, triazine, oxazine, oxathiazine, oxadiazine, indoline, benzimidazole, indazole, indenozine, benzoxazole, benzisoxazole, benzothiazole, quinoline, isoquinoline, cinnoline, quinazoline, quinoxaline, naphthyridine, phthalazine, pteridine, xanthene, acridine, phenazine, phenothiazine, benzofuropyridine, furobipyridine, benzothienopyridine, thienobipyridine, cinnolino, benzoselenophenopyridine, selenobenzene, preferably dibenzothiophene, dibenzofuran, dibenzoselenophene, carbazole, indolocarbazole, imidazole, pyridine, triazine, benzimidazole, 1, 2-azaborine, 1, 3-azaborine, 1, 4-azaborine, borazole, and aza analogues thereof. In addition, the heteroaryl group may be optionally substituted.
Alkoxy-is represented by-O-alkyl. Examples and preferred examples of the alkyl group are the same as those described above. Examples of the alkoxy group having 1 to 20 carbon atoms, preferably 1 to 6 carbon atoms include methoxy, ethoxy, propoxy, butoxy, pentyloxy, and hexyloxy. The alkoxy group having 3 or more carbon atoms may be linear, cyclic or branched.
Aryloxy-is represented by-O-aryl or-O-heteroaryl. Examples and preferred examples of aryl and heteroaryl groups are the same as described above. Examples of the aryloxy group having 6 to 40 carbon atoms include a phenoxy group and a biphenyloxy group.
Aralkyl-as used herein, an alkyl group having an aryl substituent. In addition, the aralkyl group may be optionally substituted. Examples of the aralkyl group include benzyl, 1-phenylethyl, 2-phenylethyl, 1-phenylisopropyl, 2-phenylisopropyl, phenyl tert-butyl, α -naphthylmethyl, 1- α -naphthylethyl, 2- α -naphthylethyl, 1- α -naphthylisopropyl, 2- α -naphthylisopropyl, β -naphthylmethyl, 1- β -naphthylethyl, 2- β -naphthylethyl, 1- β -naphthylisopropyl, 2- β -naphthylisopropyl, p-methylbenzyl, m-methylbenzyl, o-methylbenzyl, p-chlorobenzyl, m-chlorobenzyl, o-chlorobenzyl, p-bromobenzyl, m-bromobenzyl, o-bromobenzyl, p-iodobenzyl, m-iodobenzyl, o-iodobenzyl, p-hydroxybenzyl, m-hydroxybenzyl, o-hydroxybenzyl, p-aminobenzyl, m-aminobenzyl, o-aminobenzyl, p-nitrobenzyl, m-nitrobenzyl, o-nitrobenzyl, p-cyanobenzyl, m-cyanobenzyl, o-cyanobenzyl, 1-hydroxy-2-phenylisopropyl and 1-chloro-2-phenylisopropyl. Among the above, benzyl, p-cyanobenzyl, m-cyanobenzyl, o-cyanobenzyl, 1-phenylethyl, 2-phenylethyl, 1-phenylisopropyl and 2-phenylisopropyl are preferable.
The term "aza" in aza-dibenzofuran, aza-dibenzothiophene, etc., means that one or more C-H groups in the corresponding aromatic moiety are replaced by a nitrogen atom. For example, azatriphenylenes include dibenzo [ f, h ] quinoxalines, dibenzo [ f, h ] quinolines, and other analogs having two or more nitrogens in the ring system. Other nitrogen analogs of the aza derivatives described above will be readily apparent to one of ordinary skill in the art, and all such analogs are intended to be encompassed by the term as described herein.
In this disclosure, unless otherwise defined, when any one of the terms in the group consisting of: substituted alkyl, substituted cycloalkyl, substituted heteroalkyl, substituted aralkyl, substituted alkoxy, substituted aryloxy, substituted alkenyl, substituted aryl, substituted heteroaryl, substituted alkylsilyl, substituted arylsilyl, substituted amine, substituted acyl, substituted carbonyl, substituted carboxylic acid, substituted ester, substituted sulfinyl, substituted sulfonyl, substituted phosphino, meaning alkyl, cycloalkyl, heteroalkyl, aralkyl, alkoxy, aryloxy, alkenyl, aryl, heteroaryl, alkylsilyl, arylsilyl, amine, acyl, carbonyl, carboxylic acid, ester, sulfinyl, sulfonyl and phosphino, any of which may be substituted by one or more groups selected from deuterium, halogen, unsubstituted alkyl having 1 to 20 carbon atoms, unsubstituted cycloalkyl having 3 to 20 ring carbon atoms, unsubstituted heteroalkyl having 1 to 20 carbon atoms, unsubstituted aralkyl having 7 to 30 carbon atoms, unsubstituted alkoxy having 1 to 20 carbon atoms, unsubstituted aryloxy having 6 to 30 carbon atoms, unsubstituted alkenyl having 2 to 20 carbon atoms, unsubstituted aryl having 6 to 30 carbon atoms, unsubstituted heteroaryl having 3 to 30 carbon atoms, unsubstituted alkylsilyl having 3 to 20 carbon atoms, unsubstituted arylsilyl having 6 to 20 carbon atoms, unsubstituted amine group having 0 to 20 carbon atoms, acyl group, carbonyl group, carboxylic acid group, ester group, cyano group, isocyano group, mercapto group, sulfinyl group, sulfonyl group, phosphino group, and combinations thereof.
It will be understood that when a molecular fragment is described as a substituent or otherwise attached to another moiety, its name may be written depending on whether it is a fragment (e.g., phenyl, phenylene, naphthyl, dibenzofuranyl) or depending on whether it is an entire molecule (e.g., benzene, naphthalene, dibenzofuran). As used herein, these different ways of specifying substituents or linking fragments are considered to be equivalent.
In the compounds mentioned in the present disclosure, a hydrogen atom may be partially or completely replaced by deuterium. Other atoms such as carbon and nitrogen may also be replaced by their other stable isotopes. Substitution of other stable isotopes in the compounds may be preferred because it enhances the efficiency and stability of the device.
In the compounds mentioned in the present disclosure, multiple substitution means that a double substitution is included up to the range of the maximum available substitutions. When a substituent in a compound mentioned in the present disclosure represents multiple substitution (including di-substitution, tri-substitution, tetra-substitution, etc.), that is, it means that the substituent may exist at a plurality of available substitution positions on its connecting structure, and the substituent existing at each of the plurality of available substitution positions may be the same structure or different structures.
In the compounds mentioned in the present disclosure, adjacent substituents in the compounds cannot be linked to form a ring unless specifically defined, for example, adjacent substituents can be optionally linked to form a ring. In the compounds mentioned in the present disclosure, adjacent substituents can be optionally linked to form a ring, including both the case where adjacent substituents may be linked to form a ring and the case where adjacent substituents are not linked to form a ring. When adjacent substituents can optionally be joined to form a ring, the ring formed can be monocyclic or polycyclic, as well as alicyclic, heteroalicyclic, aromatic or heteroaromatic rings. In this expression, adjacent substituents may refer to substituents bonded to the same atom, substituents bonded to carbon atoms directly bonded to each other, or substituents bonded to carbon atoms further away. Preferably, adjacent substituents refer to substituents bonded to the same carbon atom as well as substituents bonded to carbon atoms directly bonded to each other.
The expression that adjacent substituents can optionally be linked to form a ring is also intended to mean that two substituents bonded to the same carbon atom are linked to each other by a chemical bond to form a ring, which can be exemplified by the following formula:
Figure BDA0003001663800000071
the expression that adjacent substituents can optionally be linked to form a ring is also intended to mean that two substituents bonded to carbon atoms directly bonded to each other are linked to each other by a chemical bond to form a ring, which can be exemplified by the following formula:
Figure BDA0003001663800000072
further, the expression that adjacent substituents can be optionally connected to form a ring is also intended to be taken to mean that, in the case where one of two substituents bonded to carbon atoms directly bonded to each other represents hydrogen, the second substituent is bonded at a position to which the hydrogen atom is bonded, thereby forming a ring. This is exemplified by the following equation:
Figure BDA0003001663800000081
according to one embodiment of the present invention, a metal complex is disclosed comprising a ligand La,LaHas a structure represented by formula 1:
Figure BDA0003001663800000082
wherein, ring A and ring B are each independently selected from five-membered unsaturated carbocyclic ring, aromatic ring with 6-30 carbon atoms or heteroaromatic ring with 3-30 carbon atoms;
Rithe same or different at each occurrence represents mono-, poly-, or no substitution; riiThe same or different at each occurrence represents mono-, poly-, or no substitution;
y is selected from SiRyRy,GeRyRy,NRy,PRyO, S or Se;
when two R are simultaneously presentyWhen two R are presentyMay be the same or different; for example, when Y is selected from SiRyRyWhen two R are presentyMay be the same or different; as another example, when Y is selected from GeRyRyWhen two R are presentyMay be the same or different;
X1-X2selected from CR, identically or differently at each occurrencexOr N;
R、Ri、Rii、Rxand RyEach occurrence, the same or different, is selected from the group consisting of: hydrogen, deuterium, halogen, substituted or unsubstituted alkyl having 1 to 20 carbon atoms, substituted or unsubstituted cycloalkyl having 3 to 20 ring carbon atoms, substituted or unsubstitutedA heteroalkyl group having 1 to 20 carbon atoms, a substituted or unsubstituted aralkyl group having 7 to 30 carbon atoms, a substituted or unsubstituted alkoxy group having 1 to 20 carbon atoms, a substituted or unsubstituted aryloxy group having 6 to 30 carbon atoms, a substituted or unsubstituted alkenyl group having 2 to 20 carbon atoms, a substituted or unsubstituted aryl group having 6 to 30 carbon atoms, a substituted or unsubstituted heteroaryl group having 3 to 30 carbon atoms, a substituted or unsubstituted alkylsilyl group having 3 to 20 carbon atoms, a substituted or unsubstituted arylsilyl group having 6 to 20 carbon atoms, a substituted or unsubstituted amine group having 0 to 20 carbon atoms, an acyl group, a carbonyl group, a carboxylic acid group, an ester group, a cyano group, an isocyano group, a mercapto group, a sulfinyl group, a sulfonyl group, a phosphino group, and combinations thereof;
adjacent substituents Ri、Rx、RyR and RiiCan optionally be linked to form a ring;
the metal is selected from metals having a relative atomic mass greater than 40.
In this context, adjacent substituents Ri、Rx、RyR and RiiCan optionally be linked to form a ring, is intended to mean a group in which adjacent substituents are present, for example two substituents RiIn between, two substituents RiiIn between, two substituents RyIn between, two substituents RxOf a substituent RiAnd RxIn the substituent R and RyAnd a substituent RiiAnd R, any one or more of these substituent groups may be bonded to form a ring. Obviously, none of these substituents may be connected to each other to form a ring.
According to one embodiment of the invention, wherein the metal complex optionally comprises further ligands, which may be related to the LaOptionally linked to form a tridentate, tetradentate, pentadentate or hexadentate ligand.
According to one embodiment of the invention, ring a and ring B are each independently selected from a five-membered unsaturated carbocyclic ring, an aromatic ring having 6 to 18 carbon atoms, or a heteroaromatic ring having 3 to 18 carbon atoms.
According to one embodiment of the invention, ring a or ring B is each independently selected from a five-membered unsaturated carbocyclic ring, an aromatic ring having 6 to 18 carbon atoms, or a heteroaromatic ring having 3 to 18 carbon atoms.
According to one embodiment of the invention, ring a and ring B are each independently selected from a five-membered unsaturated carbocyclic ring, an aromatic ring having 6 to 10 carbon atoms, or a heteroaromatic ring having 3 to 10 carbon atoms.
According to one embodiment of the invention, ring a or ring B is each independently selected from a five-membered unsaturated carbocyclic ring, an aromatic ring having 6 to 10 carbon atoms, or a heteroaromatic ring having 3 to 10 carbon atoms.
According to an embodiment of the present invention, wherein said LaA structure selected from the group consisting of structures represented by any one of formulas 2 to 19 and 22 to 23:
Figure BDA0003001663800000091
wherein,
in the formulae 2 to 19 and 22 to 23, X1-X2Each independently selected from CRxOr N; x3-X7Each independently selected from CRiOr N; a. the1-A6Each independently selected from CRiiOr N;
z is selected, identically or differently on each occurrence, from CRiiiRiii,SiRiiiRiii,PRiiiO, S or NRiii(ii) a When two R are simultaneously presentiiiWhen two R are presentiiiThe same or different; for example, when Z is selected from CRiiiRiiiWhen two R are presentiiiThe same or different; as another example, when Z is selected from SiRiiiRiiiWhen two R are presentiiiThe same or different;
y is selected from SiRyRy,NRy,PRyO, S or Se; when two R are simultaneously presentyWhen two R are presentyMay be the same or different; for example when Y is selected from SiRyRyWhen two R are presentyMay be the same or different;
R,Ri,Rii,Rx,Riiieach occurrence, the same or different, is selected from the group consisting of: hydrogen, deuterium, halogen, substituted or unsubstituted alkyl groups having 1 to 20 carbon atoms, substituted or unsubstituted cycloalkyl groups having 3 to 20 ring carbon atoms, substituted or unsubstituted heteroalkyl groups having 1 to 20 carbon atoms, substituted or unsubstituted aralkyl groups having 7 to 30 carbon atoms, substituted or unsubstituted alkoxy groups having 1 to 20 carbon atoms, substituted or unsubstituted aryloxy groups having 6 to 30 carbon atoms, substituted or unsubstituted alkenyl groups having 2 to 20 carbon atoms, substituted or unsubstituted aryl groups having 6 to 30 carbon atoms, substituted or unsubstituted heteroaryl groups having 3 to 30 carbon atoms, substituted or unsubstituted alkylsilyl groups having 3 to 20 carbon atoms, substituted or unsubstituted arylsilyl groups having 6 to 20 carbon atoms, substituted or unsubstituted amine groups having 0-20 carbon atoms, acyl groups, carbonyl groups, carboxylic acid groups, ester groups, cyano groups, isocyano groups, mercapto groups, sulfinyl groups, sulfonyl groups, phosphino groups, and combinations thereof;
adjacent substituents R, Rx,Ry,Ri,Rii,RiiiCan optionally be linked to form a ring.
In this context, the adjacent substituents R, Rx,Ry,Ri,Rii,RiiiCan optionally be linked to form a ring, is intended to mean a group in which adjacent substituents are present, for example two substituents RiIn between, two substituents RiiIn between, two substituents RxIn between, two substituents RyIn between, two substituents RiiiOf a substituent RiAnd RxOf a substituent RiiAnd RiiiIn the substituent R and RyOf R is a substituentyAnd RiiiAnd the substituents R and RiiiAny one or more of these substituent groups may be linked to form a ring. Obviously, none of these substituents may be connected to each other to form a ring.
According to an embodiment of the invention, wherein LaSelected from the group consisting of tables of formula 2, formula 9, formula 11, and formula 12The structure shown.
According to an embodiment of the invention, wherein LaSelected from the structures represented by formula 2.
According to an embodiment of the present invention, wherein, in formula 2-formula 19 and formula 22-formula 23, X1-XnAnd/or A1-AmAt least one of them is selected from N, XnCorresponding to the X1-X7The largest numerical order in any one of the formulae 2 to 19 and 22 to 23, wherein A ismCorresponds to the A1-A6The largest sequence number among any one of the formulae 2 to 19 and 22 to 23; for example, for formula 2, the XnCorresponding to the X1-X7X having the largest number in formula 25Said A ismCorresponds to the A1-A6The one with the largest sequence number A existing in formula 24I.e., in formula 2, X1-X5And/or A1-A4At least one of which is selected from N. As another example, for formula 12, the XnCorresponding to the X1-X7X having the largest number in formula 123Said A ismCorresponds to the A1-A6The one with the largest sequence number A in formula 124I.e. X in formula 121-X3And/or A1-A4At least one of which is selected from N.
According to an embodiment of the present invention, wherein, in formula 2-formula 19 and formula 22-formula 23, X1-XnAt least one of them is selected from N, XnCorresponding to the X1-X7The largest sequence number is present in any of formulae 2 to 19 and 22 to 23.
According to an embodiment of the present invention, wherein, in formula 2-formula 19 and formula 22-formula 23, X2Is N.
According to an embodiment of the present invention, wherein, in formula 2-formula 19 and formula 22-formula 23, X1-X2Each independently selected from CRx;X3-X7Each independently selected from CRi;A1-A6Each independently selected from CRii(ii) a Adjacent substituents Rx、Ri、RiiCan optionally be linked to form a ring.
In this example, the adjacent substituents Rx、Ri、RiiCan optionally be linked to form a ring, is intended to mean a group in which adjacent substituents are present, for example two substituents RiIn between, two substituents RiiIn between, two substituents RxAnd a substituent RiAnd RxAny one or more of these substituent groups may be linked to form a ring. Obviously, none of these substituents may be linked to each other to form a ring.
According to an embodiment of the present invention, wherein, in formula 2-formula 19 and formula 22-formula 23, X1-X2Each independently selected from CRx;X3-X7Each independently selected from CRi;A1-A6Each independently selected from CRii(ii) a And said R isx、Ri、RiiEach occurrence, the same or different, is selected from the group consisting of: hydrogen, deuterium, halogen, substituted or unsubstituted alkyl groups having 1 to 20 carbon atoms, substituted or unsubstituted cycloalkyl groups having 3 to 20 ring carbon atoms, substituted or unsubstituted aryl groups having 6 to 30 carbon atoms, substituted or unsubstituted heteroaryl groups having 3 to 30 carbon atoms, substituted or unsubstituted alkylsilyl groups having 3 to 20 carbon atoms, substituted or unsubstituted arylsilyl groups having 6 to 20 carbon atoms, cyano groups, and combinations thereof; adjacent substituents Rx、Ri、RiiCan optionally be linked to form a ring.
According to an embodiment of the present invention, wherein, in formula 2-formula 19 and formula 22-formula 23, X1-X2Each independently selected from CRx;X3-X7Each independently selected from CRi;A1-A6Each independently selected from CRii(ii) a And said R isx、Ri、RiiAt least two of which, on each occurrence, are selected, identically or differently, from the group consisting of: deuterium, halogen, substituted or unsubstituted alkyl having 1 to 20 carbon atoms, substitutedOr unsubstituted cycloalkyl having 3 to 20 ring carbon atoms, substituted or unsubstituted aryl having 6 to 30 carbon atoms, substituted or unsubstituted heteroaryl having 3 to 30 carbon atoms, substituted or unsubstituted alkylsilyl having 3 to 20 carbon atoms, substituted or unsubstituted arylsilyl having 6 to 20 carbon atoms, cyano, and combinations thereof; adjacent substituents Rx、Ri、RiiCan optionally be linked to form a ring.
In this embodiment, R isx、Ri、RiiAt least two of which, on each occurrence, are selected, identically or differently, from the group of substituents mentioned, is intended to mean that the substituents consisting of two RxSubstituent, all RiSubstituents and all RiiAt least two substituents in a group of substituents, which are identical or different on each occurrence, are selected from the group of substituents.
According to an embodiment of the present invention, wherein, in formula 2-formula 19 and formula 22-formula 23, X1-X2Each independently selected from CRx;X3-X7Each independently selected from CRi;A1-A6Each independently selected from CRii(ii) a And said R isx、Ri、RiiAt least three of which, identically or differently on each occurrence, are selected from the group consisting of: deuterium, halogen, substituted or unsubstituted alkyl groups having 1 to 20 carbon atoms, substituted or unsubstituted cycloalkyl groups having 3 to 20 ring carbon atoms, substituted or unsubstituted aryl groups having 6 to 30 carbon atoms, substituted or unsubstituted heteroaryl groups having 3 to 30 carbon atoms, substituted or unsubstituted alkylsilyl groups having 3 to 20 carbon atoms, substituted or unsubstituted arylsilyl groups having 6 to 20 carbon atoms, cyano groups, and combinations thereof; adjacent substituents Rx、Ri、RiiCan optionally be linked to form a ring.
In this embodiment, R isx、Ri、RiiAt least three of which, on each occurrence, are selected, identically or differently, from the group of substituents mentioned, is intended to mean that the substituents consisting of two RxSubstituent, all RiSubstituents and all RiiSubstitutionAt least three substituents in the group of substituents are selected, identically or differently on each occurrence, from the group of substituents mentioned.
According to an embodiment of the present invention, wherein, in formula 2-formula 11 and formula 22-formula 23, X4And X5Each independently selected from CRi(ii) a In formula 12-formula 19, X3Selected from the group consisting of CRi
According to an embodiment of the present invention, wherein, in formula 2-formula 11 and formula 22-formula 23, X4Or X5Selected from the group consisting of CRi(ii) a In formula 12 to formula 19, X3Selected from the group consisting of CRi
According to an embodiment of the present invention, wherein, in formula 2-formula 11 and formula 22-formula 23, X4And X5Each independently selected from CRi(ii) a In formula 12 to formula 19, X3Selected from the group consisting of CRi(ii) a And said R isiEach occurrence is the same or different and is selected from the group consisting of hydrogen, deuterium, halogen, substituted or unsubstituted alkyl having 1 to 20 carbon atoms, substituted or unsubstituted cycloalkyl having 3 to 20 ring carbon atoms, substituted or unsubstituted aryl having 6 to 30 carbon atoms, substituted or unsubstituted heteroaryl having 3 to 30 carbon atoms, substituted or unsubstituted alkylsilyl having 3 to 20 carbon atoms, substituted or unsubstituted arylsilyl having 6 to 20 carbon atoms, cyano, or combinations thereof.
According to an embodiment of the present invention, wherein, in formula 2-formula 11 and formula 22-formula 23, X4Or X5Selected from the group consisting of CRi(ii) a In formula 12-formula 19, X3Selected from the group consisting of CRi(ii) a And said R isiEach occurrence is the same or different and is selected from the group consisting of hydrogen, deuterium, halogen, substituted or unsubstituted alkyl having 1 to 20 carbon atoms, substituted or unsubstituted cycloalkyl having 3 to 20 ring carbon atoms, substituted or unsubstituted aryl having 6 to 30 carbon atoms, substituted or unsubstituted heteroaryl having 3 to 30 carbon atoms, substituted or unsubstituted alkylsilyl having 3 to 20 carbon atoms, substituted or unsubstituted arylsilyl having 6 to 20 carbon atoms, cyano, or combinations thereof.
According to an embodiment of the present invention, among them, in the formulas 2-11 and 22-typeIn 23, X4And X5Each independently selected from CRi(ii) a In formula 12-formula 19, X3Selected from the group consisting of CRi(ii) a Wherein said RiEach occurrence, the same or different, is selected from the group consisting of: hydrogen, deuterium, fluoro, methyl, ethyl, isopropyl, isobutyl, tert-butyl, neopentyl, cyclopentyl, cyclopentylmethyl, cyclohexyl, norbornyl, adamantyl, trimethylsilyl, isopropyldimethylsilyl, phenyldimethylsilyl, trifluoromethyl, cyano, phenyl, and combinations thereof.
According to an embodiment of the present invention, wherein, in formula 2-formula 11 and formula 22-formula 23, X4Or X5Selected from the group consisting of CRi(ii) a In formula 12-formula 19, X3Selected from the group consisting of CRi(ii) a Wherein said RiEach occurrence, the same or different, is selected from the group consisting of: hydrogen, deuterium, fluoro, methyl, ethyl, isopropyl, isobutyl, tert-butyl, neopentyl, cyclopentyl, cyclopentylmethyl, cyclohexyl, norbornyl, adamantyl, trimethylsilyl, isopropyldimethylsilyl, phenyldimethylsilyl, trifluoromethyl, cyano, phenyl, and combinations thereof.
According to an embodiment of the present invention, wherein, in formula 2-formula 19 and formula 22-formula 23, R is selected from hydrogen, deuterium, halogen, substituted or unsubstituted alkyl group having 1 to 20 carbon atoms, substituted or unsubstituted cycloalkyl group having 3 to 20 ring carbon atoms, substituted or unsubstituted aryl group having 6 to 30 carbon atoms, substituted or unsubstituted heteroaryl group having 3 to 30 carbon atoms, substituted or unsubstituted alkylsilyl group having 3 to 20 carbon atoms, substituted or unsubstituted arylsilyl group having 6 to 20 carbon atoms, or a combination thereof.
According to an embodiment of the present invention, wherein, in formula 2-formula 19 and formula 22-formula 23, R is selected from hydrogen, deuterium, fluorine, methyl, ethyl, isopropyl, isobutyl, tert-butyl, neopentyl, cyclopentyl, cyclopentylmethyl, deuterated methyl, deuterated ethyl, deuterated isopropyl, deuterated tert-butyl, deuterated neopentyl, deuterated cyclopentyl, deuterated cyclopentylmethyl, deuterated cyclohexyl, trimethylsilyl, or a combination thereof.
According to one embodiment of the present invention, wherein, in formula 2-formula 19 and formula 22-formula 23, Y is selected from O or S.
According to one embodiment of the present invention, wherein, in formula 2-formula 19 and formula 22-formula 23, Y is selected from O.
According to one embodiment of the present invention, wherein, in formula 2-formula 19 and formula 22-formula 23, X1And X2Each independently selected from CRx
According to an embodiment of the present invention, wherein, in formula 2-formula 19 and formula 22-formula 23, X1And X2Each independently selected from CRx(ii) a And said R isxEach occurrence is the same or different and is selected from the group consisting of hydrogen, deuterium, halogen, substituted or unsubstituted alkyl groups having 1 to 20 carbon atoms, substituted or unsubstituted cycloalkyl groups having 3 to 20 ring carbon atoms, substituted or unsubstituted aryl groups having 6 to 30 carbon atoms, substituted or unsubstituted heteroaryl groups having 3 to 30 carbon atoms, substituted or unsubstituted alkylsilyl groups having 3 to 20 carbon atoms, substituted or unsubstituted arylsilyl groups having 6 to 20 carbon atoms, or combinations thereof.
According to an embodiment of the present invention, wherein, in formula 2-formula 19 and formula 22-formula 23, X1Selected from the group consisting of CRx,X2Is N.
According to an embodiment of the present invention, wherein, in formula 2-formula 19 and formula 22-formula 23, X1Selected from the group consisting of CRx,X2Is N; and said R isxEach occurrence is the same or different and is selected from the group consisting of hydrogen, deuterium, halogen, substituted or unsubstituted alkyl groups having 1 to 20 carbon atoms, substituted or unsubstituted cycloalkyl groups having 3 to 20 ring carbon atoms, substituted or unsubstituted aryl groups having 6 to 30 carbon atoms, substituted or unsubstituted heteroaryl groups having 3 to 30 carbon atoms, substituted or unsubstituted alkylsilyl groups having 3 to 20 carbon atoms, substituted or unsubstituted arylsilyl groups having 6 to 20 carbon atoms, or combinations thereof.
According to one embodiment of the invention, wherein the ligand LaHas a structure represented by formula 20 or formula 21:
Figure BDA0003001663800000121
wherein, in the formulae 20 and 21,
y is selected from O or S;
Rx1、Rx2、Ri1、Ri2、Ri3、Rii1、Rii2、Rii3、Rii4each occurrence, the same or different, is selected from the group consisting of: hydrogen, deuterium, halogen, substituted or unsubstituted alkyl groups having 1 to 20 carbon atoms, substituted or unsubstituted cycloalkyl groups having 3 to 20 ring carbon atoms, substituted or unsubstituted aryl groups having 6 to 30 carbon atoms, substituted or unsubstituted heteroaryl groups having 3 to 30 carbon atoms, substituted or unsubstituted alkylsilyl groups having 3 to 20 carbon atoms, substituted or unsubstituted arylsilyl groups having 6 to 20 carbon atoms, or combinations thereof;
r is selected, identically or differently on each occurrence, from the group consisting of: hydrogen, deuterium, halogen, substituted or unsubstituted alkyl groups having 1 to 20 carbon atoms, substituted or unsubstituted cycloalkyl groups having 3 to 20 ring carbon atoms, substituted or unsubstituted aryl groups having 6 to 30 carbon atoms, substituted or unsubstituted heteroaryl groups having 3 to 30 carbon atoms, substituted or unsubstituted alkylsilyl groups having 3 to 20 carbon atoms, substituted or unsubstituted arylsilyl groups having 6 to 20 carbon atoms, substituted or unsubstituted amine groups having 0 to 20 carbon atoms, and combinations thereof.
According to one embodiment of the invention, wherein the ligand LaHas a structure represented by formula 20 or formula 21:
Figure BDA0003001663800000131
wherein, in the formulae 20 and 21,
y is selected from O or S;
Rx1、Rx2、Ri1、Ri2、Ri3neutralization/or Rii1、Rii2、Rii3、Rii4Is selected, identically or differently on each occurrence, from the group consisting of: deuterium, halogen, substituted or unsubstituted alkyl having 1 to 20 carbon atoms, substituted or unsubstituted cycloalkyl having 3 to 20 ring carbon atoms, substituted or unsubstituted aryl having 6 to 30 carbon atoms, substituted or unsubstituted heteroaryl having 3 to 30 carbon atoms, substituted or unsubstituted alkylsilyl having 3 to 20 carbon atoms, substituted or unsubstituted arylsilyl having 6 to 20 carbon atoms, or a combination thereof; r is selected from the group consisting of halogen, substituted or unsubstituted alkyl groups having 1 to 20 carbon atoms, substituted or unsubstituted cycloalkyl groups having 3 to 20 ring carbon atoms, substituted or unsubstituted aryl groups having 6 to 30 carbon atoms, substituted or unsubstituted heteroaryl groups having 3 to 30 carbon atoms, substituted or unsubstituted alkylsilyl groups having 3 to 20 carbon atoms, substituted or unsubstituted arylsilyl groups having 6 to 20 carbon atoms, or combinations thereof.
According to one embodiment of the invention, wherein the ligand LaHas a structure represented by formula 20 or formula 21:
Figure BDA0003001663800000132
wherein, in the formulae 20 and 21,
y is selected from O or S;
Rx1、Rx2、Ri1、Ri2、Ri3neutralization/or Rii1、Rii2、Rii3And Rii4Is selected, identically or differently on each occurrence, from the group consisting of: a substituted or unsubstituted alkyl group having 1 to 20 carbon atoms, a substituted or unsubstituted cycloalkyl group having 3 to 20 ring carbon atoms, a substituted or unsubstituted aryl group having 6 to 30 carbon atoms, a substituted or unsubstituted heteroaryl group having 3 to 30 carbon atoms, a substituted or unsubstituted alkylsilyl group having 3 to 20 carbon atoms, a substituted or unsubstituted arylsilyl group having 6 to 20 carbon atoms, or a combination thereof; r is selected from substituted or unsubstituted alkyl groups having 1 to 20 carbon atoms, substituted or unsubstitutedA substituted or unsubstituted aryl group having 6 to 30 carbon atoms, a substituted or unsubstituted heteroaryl group having 3 to 30 carbon atoms, a substituted or unsubstituted alkylsilyl group having 3 to 20 carbon atoms, a substituted or unsubstituted arylsilyl group having 6 to 20 carbon atoms, or a combination thereof.
According to one embodiment of the invention, wherein the ligand LaHas a structure represented by formula 20 or formula 21:
Figure BDA0003001663800000141
wherein, in the formulae 20 and 21,
y is selected from O or S;
Ri2selected from the group consisting of: deuterium, halogen, substituted or unsubstituted alkyl groups having 1 to 20 carbon atoms, substituted or unsubstituted cycloalkyl groups having 3 to 20 ring carbon atoms, substituted or unsubstituted aryl groups having 6 to 30 carbon atoms, substituted or unsubstituted heteroaryl groups having 3 to 30 carbon atoms, substituted or unsubstituted alkylsilyl groups having 3 to 20 carbon atoms, substituted or unsubstituted arylsilyl groups having 6 to 20 carbon atoms, or combinations thereof;
r is selected from the group consisting of: halogen, substituted or unsubstituted alkyl having 1 to 20 carbon atoms, substituted or unsubstituted cycloalkyl having 3 to 20 ring carbon atoms, substituted or unsubstituted aryl having 6 to 30 carbon atoms, substituted or unsubstituted heteroaryl having 3 to 30 carbon atoms, substituted or unsubstituted alkylsilyl having 3 to 20 carbon atoms, substituted or unsubstituted arylsilyl having 6 to 20 carbon atoms, or combinations thereof; rii1、Rii2、Rii3、Rii4Is selected, identically or differently on each occurrence, from the group consisting of: deuterium, halogen, substituted or unsubstituted alkyl having 1 to 20 carbon atoms, substituted or unsubstituted cycloalkyl having 3 to 20 ring carbon atoms, substituted or unsubstituted aryl having 6 to 30 carbon atoms, substituted or unsubstituted heteroaryl having 3 to 30 carbon atomsA group, a substituted or unsubstituted alkylsilyl group having 3 to 20 carbon atoms, a substituted or unsubstituted arylsilyl group having 6 to 20 carbon atoms, or a combination thereof.
According to one embodiment of the invention, wherein the ligand LaHas a structure represented by formula 20 or formula 21:
Figure BDA0003001663800000142
wherein, in the formulae 20 and 21,
y is selected from O or S;
Ri2selected from the group consisting of: a substituted or unsubstituted alkyl group having 1 to 20 carbon atoms, a substituted or unsubstituted cycloalkyl group having 3 to 20 ring carbon atoms, a substituted or unsubstituted aryl group having 6 to 30 carbon atoms, a substituted or unsubstituted heteroaryl group having 3 to 30 carbon atoms, a substituted or unsubstituted alkylsilyl group having 3 to 20 carbon atoms, a substituted or unsubstituted arylsilyl group having 6 to 20 carbon atoms, or a combination thereof;
r is selected from the group consisting of: a substituted or unsubstituted alkyl group having 1 to 20 carbon atoms, a substituted or unsubstituted cycloalkyl group having 3 to 20 ring carbon atoms, a substituted or unsubstituted aryl group having 6 to 30 carbon atoms, a substituted or unsubstituted heteroaryl group having 3 to 30 carbon atoms, a substituted or unsubstituted alkylsilyl group having 3 to 20 carbon atoms, a substituted or unsubstituted arylsilyl group having 6 to 20 carbon atoms, or a combination thereof; rii1、Rii2、Rii3、Rii4Is selected, identically or differently on each occurrence, from the group consisting of: a substituted or unsubstituted alkyl group having 1 to 20 carbon atoms, a substituted or unsubstituted cycloalkyl group having 3 to 20 ring carbon atoms, a substituted or unsubstituted aryl group having 6 to 30 carbon atoms, a substituted or unsubstituted heteroaryl group having 3 to 30 carbon atoms, a substituted or unsubstituted alkylsilyl group having 3 to 20 carbon atoms, a substituted or unsubstituted arylsilyl group having 6 to 20 carbon atoms, or a combination thereof.
According to the inventionAn embodiment of the present invention, wherein, in the formulas 20 and 21, Rii1、Rii2、Rii3Of (e.g., R)ii1Or Rii2Or Rii3) Or two (e.g. R)ii1And Rii2Or Rii2And Rii3Or Rii1And Rii3) Each occurrence, the same or different, is selected from the group consisting of: a substituted or unsubstituted alkyl group having 1 to 20 carbon atoms, a substituted or unsubstituted cycloalkyl group having 3 to 20 ring carbon atoms, a substituted or unsubstituted aryl group having 6 to 30 carbon atoms, a substituted or unsubstituted heteroaryl group having 3 to 30 carbon atoms, a substituted or unsubstituted alkylsilyl group having 3 to 20 carbon atoms, a substituted or unsubstituted arylsilyl group having 6 to 20 carbon atoms, or a combination thereof.
According to an embodiment of the present invention, wherein, in formula 20 and formula 21, Rx1、Rx2、Ri1、Ri2、Ri3、Rii1、Rii2、Rii3、Rii4Each occurrence of at least one of R, is selected, identically or differently, from the group consisting of: substituted or unsubstituted alkyl groups having 3 to 20 carbon atoms, substituted or unsubstituted cycloalkyl groups having 3 to 20 ring carbon atoms, substituted or unsubstituted alkylsilyl groups having 3 to 20 carbon atoms, and combinations thereof.
In this embodiment, Rx1、Rx2、Ri1、Ri2、Ri3、Rii1、Rii2、Rii3、Rii4At least one of R, taken on each occurrence, identically or differently, is selected from said group of substituents, intended to mean: rx1、Rx2Is selected, identically or differently on each occurrence, from the group of substituents, and/or Ri1、Ri2、Ri3Is selected, identically or differently on each occurrence, from the group of substituents, and/or Rii1、Rii2、Rii3、Rii4Is selected from said group of substituents, identically or differently on each occurrence, and/or R is selected from said group of substituents.
According to one embodiment of the present invention, wherein, in the formulas 20 and 21, Ri2、Ri3、Rii1、Rii2、Rii3Each occurrence of at least one of R, is selected, identically or differently, from the group consisting of: substituted or unsubstituted alkyl groups having 3 to 20 carbon atoms, substituted or unsubstituted cycloalkyl groups having 3 to 20 ring carbon atoms, substituted or unsubstituted alkylsilyl groups having 3 to 20 carbon atoms, and combinations thereof.
In this embodiment, Ri2、Ri3、Rii1、Rii2、Rii3At least one of R, taken on each occurrence, identically or differently, is selected from said group of substituents, intended to mean: ri2、Ri3Is selected, identically or differently on each occurrence, from the group of substituents, and/or Rii1、Rii2、Rii3Is selected, identically or differently on each occurrence, from the group of substituents, and/or R is selected from the group of substituents.
According to an embodiment of the present invention, wherein, in formula 20 and formula 21, Rx1、Rx2、Ri1、Ri2、Ri3、Rii1、Rii2、Rii3、Rii4Each occurrence of at least one of R, is selected, identically or differently, from the group consisting of: substituted or unsubstituted alkyl groups having 3 to 10 carbon atoms, substituted or unsubstituted cycloalkyl groups having 3 to 10 ring carbon atoms, and combinations thereof.
In this embodiment, Rx1、Rx2、Ri1、Ri2、Ri3、Rii1、Rii2、Rii3、Rii4At least one of R, taken on each occurrence, identically or differently, is selected from said group of substituents, intended to mean: rx1、Rx2Is selected, identically or differently on each occurrence, from the group of substituents, and/or Ri1、Ri2、Ri3Is selected, identically or differently on each occurrence, from the group of substituents, and/or Rii1、Rii2、Rii3、Rii4In (1)At least one is selected from said group of substituents, identically or differently on each occurrence, and/or R is selected from said group of substituents.
According to one embodiment of the present invention, wherein LaEach occurrence being selected identically or differently from La1To La1706Wherein L isa1To La1706See claim 14 for specific structure of (a).
According to an embodiment of the invention, wherein LaEach occurrence being selected identically or differently from La1To La1803Wherein L isa1To La1803See claim 14 for specific structure of (a).
According to an embodiment of the invention, wherein LaEach occurrence being selected identically or differently from La1To La1931Wherein L isa1To La1931See claim 14 for specific structure of (a).
According to an embodiment of the present invention, wherein said La1To La1931The hydrogen in the structure of (a) can be partially or completely substituted with deuterium.
According to one embodiment of the present invention, wherein the metal complex has M (L)a)m(Lb)n(Lc)qThe structure of (1);
wherein the metal M is selected from metals having a relative atomic mass greater than 40; l isa、LbAnd LcA first ligand, a second ligand and a third ligand, respectively, of the complex; m is 1,2 or 3, n is 0, 1 or 2, q is 0, 1 or 2, M + n + q is equal to the oxidation state of the metal M; when m is greater than 1, a plurality of LaThe same or different; when n is 2, two LbThe same or different; when q is 2, two LcThe same or different;
La、Lband LcOptionally linked to form a multidentate ligand; such as La、LbAnd LcOptionally linked to form a tetradentate or hexadentate ligand; l isa、LbAnd LcOr may be all unconnected so as not to form more than oneA dentate ligand;
Lband LcEach occurrence, the same or different, is selected from the group consisting of:
Figure BDA0003001663800000161
wherein R isa、RbAnd RcThe same or different at each occurrence indicates mono-, poly-, or no substitution;
Xbeach occurrence, the same or different, is selected from the group consisting of: o, S, Se, NRN1And CRC1RC2
XcAnd XdEach occurrence, the same or different, is selected from the group consisting of: o, S, Se and NRN2
Ra、Rb、Rc、RN1、RN2、RC1And RC2Each occurrence, the same or different, is selected from the group consisting of: hydrogen, deuterium, halogen, a substituted or unsubstituted alkyl group having 1 to 20 carbon atoms, a substituted or unsubstituted cycloalkyl group having 3 to 20 ring carbon atoms, a substituted or unsubstituted heteroalkyl group having 1 to 20 carbon atoms, a substituted or unsubstituted aralkyl group having 7 to 30 carbon atoms, a substituted or unsubstituted alkoxy group having 1 to 20 carbon atoms, a substituted or unsubstituted aryloxy group having 6 to 30 carbon atoms, a substituted or unsubstituted alkenyl group having 2 to 20 carbon atoms, a substituted or unsubstituted aryl group having 6 to 30 carbon atoms, a substituted or unsubstituted heteroaryl group having 3 to 30 carbon atoms, a substituted or unsubstituted alkylsilyl group having 3 to 20 carbon atoms, a substituted or unsubstituted arylsilyl group having 6 to 20 carbon atoms, substituted or unsubstituted amine groups having 0-20 carbon atoms, acyl groups, carbonyl groups, carboxylic acid groups, ester groups, cyano groups, isocyano groups, mercapto groups, sulfinyl groups, sulfonyl groups, phosphino groups, and combinations thereof;
wherein the adjacent substituents Ra、Rb、Rc、RN1、RN2、RC1And RC2Can optionally be linked to form a ring.
In this example, the adjacent substituents Ra、Rb、Rc、RN1、RN2、RC1And RC2Can optionally be linked to form a ring, is intended to mean a group in which adjacent substituents are present, for example two substituents RaIn between, two substituents RbIn between, two substituents RcOf a substituent RaAnd RbOf a substituent RaAnd RcOf a substituent RbAnd RcOf R is a substituentaAnd RN1Of a substituent RbAnd RN1Of a substituent RaAnd RC1Of a substituent RaAnd RC2Of R is a substituentbAnd RC1Of R is a substituentbAnd RC2Of a substituent RaAnd RN2Of a substituent RbAnd RN2And R isC1And RC2And any one or more of these substituent groups may be linked to form a ring. Obviously, none of these substituents may be linked to each other to form a ring.
In this embodiment, La、LbAnd LcCan optionally be linked to form a multidentate ligand, intended to denote La、LbAnd LcAny two or three of which can be linked to form a tetradentate or hexadentate ligand. Obviously, La、LbAnd LcOr none may be linked so as to form no polydentate ligand.
According to one embodiment of the invention, wherein the metal M is selected from Ir, Rh, Re, Os, Pt, Au or Cu.
According to one embodiment of the invention, wherein the metal M is selected from Ir, Pt or Os.
According to one embodiment of the invention, wherein the metal M is Ir.
According to an embodiment of the invention, wherein LbEach occurrence, identically or differently, is selected from the following structures:
Figure BDA0003001663800000171
wherein R is1–R7Each occurrence, the same or different, is selected from the group consisting of: hydrogen, deuterium, halogen, a substituted or unsubstituted alkyl group having 1 to 20 carbon atoms, a substituted or unsubstituted cycloalkyl group having 3 to 20 ring carbon atoms, a substituted or unsubstituted heteroalkyl group having 1 to 20 carbon atoms, a substituted or unsubstituted aralkyl group having 7 to 30 carbon atoms, a substituted or unsubstituted alkoxy group having 1 to 20 carbon atoms, a substituted or unsubstituted aryloxy group having 6 to 30 carbon atoms, a substituted or unsubstituted alkenyl group having 2 to 20 carbon atoms, a substituted or unsubstituted aryl group having 6 to 30 carbon atoms, a substituted or unsubstituted heteroaryl group having 3 to 30 carbon atoms, a substituted or unsubstituted alkylsilyl group having 3 to 20 carbon atoms, a substituted or unsubstituted arylsilyl group having 6 to 20 carbon atoms, substituted or unsubstituted amine groups having 0-20 carbon atoms, acyl groups, carbonyl groups, carboxylic acid groups, ester groups, cyano groups, isocyano groups, mercapto groups, sulfinyl groups, sulfonyl groups, phosphino groups, and combinations thereof.
According to an embodiment of the invention, wherein LbEach occurrence, identically or differently, is selected from the following structures:
Figure BDA0003001663800000172
wherein R is1-R3At least one is selected from the group consisting of substituted or unsubstituted alkyl groups having 1 to 20 carbon atoms, substituted or unsubstituted cycloalkyl groups having 3 to 20 ring carbon atoms, substituted or unsubstituted heteroalkyl groups having 1 to 20 carbon atoms, or combinations thereof; and/or R4-R6At least one of which is a substituted or unsubstituted alkyl group having 1 to 20 carbon atoms, a substituted or unsubstituted cycloalkyl group having 3 to 20 ring carbon atoms, a substituted or unsubstituted heteroalkyl group having 1 to 20 carbon atoms, or combinations thereof.
According to an embodiment of the present invention, wherein,Lbeach occurrence, identically or differently, is selected from the following structures:
Figure BDA0003001663800000173
wherein R is1-R3At least two of which are selected from substituted or unsubstituted alkyl groups having 1 to 20 carbon atoms, substituted or unsubstituted cycloalkyl groups having 3 to 20 ring carbon atoms, substituted or unsubstituted heteroalkyl groups having 1 to 20 carbon atoms, or combinations thereof; and/or R4-R6At least one of which is a substituted or unsubstituted alkyl group having 1 to 20 carbon atoms, a substituted or unsubstituted cycloalkyl group having 3 to 20 ring carbon atoms, a substituted or unsubstituted heteroalkyl group having 1 to 20 carbon atoms, or combinations thereof.
According to an embodiment of the invention, wherein LbEach occurrence, identically or differently, is selected from the following structures:
Figure BDA0003001663800000174
wherein R is1-R3At least two of which are selected from substituted or unsubstituted alkyl groups having 2 to 20 carbon atoms, substituted or unsubstituted cycloalkyl groups having 3 to 20 ring carbon atoms, substituted or unsubstituted heteroalkyl groups having 2 to 20 carbon atoms, or combinations thereof; and/or R4-R6At least two of which are selected from substituted or unsubstituted alkyl groups having 2 to 20 carbon atoms, substituted or unsubstituted cycloalkyl groups having 3 to 20 ring carbon atoms, substituted or unsubstituted heteroalkyl groups having 2 to 20 carbon atoms, or combinations thereof.
According to an embodiment of the invention, wherein LbEach occurrence being selected identically or differently from Lb1To Lb322Group of (I) LcEach occurrence being selected identically or differently from Lc1To Lc231A group of (a); said Lb1To Lb322And Lc1To Lc231See claim 18 for specific structure of (a).
According to one embodiment of the invention, wherein the metal complex has Ir (L)a)2(Lb) Or Ir (L)a)2(Lc) Or Ir (L)a)(Lc)2The structure of (1);
wherein when the metal complex has Ir (L)a)2(Lb) In the structure of (1), LaEach occurrence being selected identically or differently from La1To La1706Any one or any two of the group consisting of, LbIs selected from the group consisting of Lb1To Lb322Any one of the group consisting of; when the metal complex has Ir (L)a)2(Lc) In the structure of (1), LaEach occurrence being selected identically or differently from La1To La1706Any one or any two of the group consisting of, LcIs selected from the group consisting of Lc1To Lc231Any one of the group consisting of; when the metal complex has Ir (L)a)(Lc)2In the structure of (1), LaIs selected from the group consisting of La1To La1706Any one of the group consisting of LcEach occurrence being selected identically or differently from Lc1-Lc231Any one or any two of the group consisting of.
According to one embodiment of the present invention, wherein the metal complex has Ir (L)a)2(Lb) Or Ir (L)a)2(Lc) Or Ir (L)a)(Lc)2The structure of (1);
wherein when the metal complex has Ir (L)a)2(Lb) In the structure of (1), LaEach occurrence being selected identically or differently from La1To La1803Any one or any two of the group consisting of, LbIs selected from the group consisting of Lb1To Lb322Any one of the group consisting of; when the metal complex has Ir (L)a)2(Lc) In the structure of (1), LaEach occurrence being selected identically or differently from La1To La1803Any one or any two of the group consisting of, LcIs selected from the group consisting of Lc1To Lc231Any one of the group consisting of; when the metal complex has Ir (L)a)(Lc)2In the structure of (1), LaIs selected from the group consisting of La1To La1803Any one of the group consisting of LcEach occurrence, identically or differently, of a group selected from Lc1-Lc231Any one or any two of the group consisting of.
According to one embodiment of the invention, wherein the metal complex has Ir (L)a)2(Lb) Or Ir (L)a)2(Lc) Or Ir (L)a)(Lc)2The structure of (1);
wherein when the metal complex has Ir (L)a)2(Lb) In the structure of (1), LaEach occurrence being selected identically or differently from La1To La1931Any one or any two of the group consisting of, LbIs selected from the group consisting of Lb1To Lb322Any one of the group consisting of; when the metal complex has Ir (L)a)2(Lc) In the structure of (1), LaEach occurrence being selected identically or differently from La1To La1931Any one or any two of the group consisting of, LcIs selected from the group consisting of Lc1To Lc231Any one of the group consisting of; when the metal complex has Ir (L)a)(Lc)2In the structure of (1), LaIs selected from the group consisting of La1To La1931Any one of the group consisting of LcEach occurrence being selected identically or differently from Lc1-Lc231Any one or any two of the group consisting of.
According to an embodiment of the present invention, wherein the metal complex is selected from the group consisting of compound 1 to compound 260; the specific structures of the compound 1 to the compound 260 are shown in claim 19.
According to an embodiment of the present invention, wherein the metal complex is selected from the group consisting of compound 1 to compound 290; the specific structures of the compound 1 to the compound 290 are shown in claim 19.
According to an embodiment of the present invention, wherein the metal complex is selected from the group consisting of compound 1 to compound 312; the specific structures of the compound 1 to the compound 312 are shown in claim 19.
According to an embodiment of the present invention, there is also disclosed an electroluminescent device, including:
an anode, a cathode, a anode and a cathode,
a cathode electrode, which is provided with a cathode,
and an organic layer disposed between the anode and the cathode, the organic layer comprising a metal complex comprising a ligand La,LaHas a structure represented by formula 1:
Figure BDA0003001663800000191
wherein, ring A and ring B are each independently selected from five-membered unsaturated carbocyclic ring, aromatic ring with 6-30 carbon atoms or heteroaromatic ring with 3-30 carbon atoms;
Rithe same or different at each occurrence represents mono-, poly-, or no substitution; riiThe same or different at each occurrence represents mono-, poly-, or no substitution;
y is selected from SiRyRy,GeRyRy,NRy,PRyO, S or Se;
when two R are simultaneously presentyWhen two R are presentyMay be the same or different;
X1-X2selected from CR, identically or differently at each occurrencexOr N;
R、Ri、Rii、Rxand RyEach occurrence, identically or differently, is selected from the group consisting of: hydrogen, deuterium, halogen, substituted or unsubstituted alkyl having 1 to 20 carbon atoms, substituted or unsubstituted cycloalkyl having 3 to 20 ring carbon atoms, substituted or unsubstituted heteroalkyl having 1 to 20 carbon atoms, substituted or unsubstituted aralkyl having 7 to 30 carbon atoms, substituted or unsubstituted alkoxy, amino, or amino, or amino, or amino, or amino, or amino acids, or other substituted, or other combinations thereof, or other compounds orSubstituted or unsubstituted aryloxy having from 6 to 30 carbon atoms, substituted or unsubstituted alkenyl having from 2 to 20 carbon atoms, substituted or unsubstituted aryl having from 6 to 30 carbon atoms, substituted or unsubstituted heteroaryl having from 3 to 30 carbon atoms, substituted or unsubstituted alkylsilyl having from 3 to 20 carbon atoms, substituted or unsubstituted arylsilyl having from 6 to 20 carbon atoms, substituted or unsubstituted amine having from 0 to 20 carbon atoms, acyl, carbonyl, carboxylic acid group, ester group, cyano, isocyano, mercapto, sulfinyl, sulfonyl, phosphino, and combinations thereof;
adjacent substituents Ri、Rx、RyR and RiiCan optionally be linked to form a ring;
the metal is selected from metals having a relative atomic mass greater than 40.
According to an embodiment of the present invention, in the electroluminescent device, the organic layer is a light-emitting layer, and the metal complex is a light-emitting material.
According to one embodiment of the invention, the electroluminescent device emits red light.
According to one embodiment of the invention, the electroluminescent device emits white light.
According to one embodiment of the present invention, in the electroluminescent device, the organic layer is a light-emitting layer, and the light-emitting layer further includes at least one host material.
According to an embodiment of the invention, in the electroluminescent device, the at least one host material comprises at least one chemical group selected from the group consisting of: benzene, pyridine, pyrimidine, triazine, carbazole, azacarbazole, indolocarbazole, dibenzothiophene, azadibenzothiophene, dibenzofuran, azadibenzofuran, dibenzoselenophene, triphenylene, azatriphenylene, fluorene, silafluorene, naphthalene, quinoline, isoquinoline, quinazoline, quinoxaline, phenanthrene, azaphenanthrene, and combinations thereof.
According to another embodiment of the invention, the invention also discloses a compound combination which comprises a metal complex, wherein the specific structure of the metal complex is shown in any one of the embodiments.
In combination with other materials
The materials described herein for use in particular layers in an organic light emitting device may be used in combination with various other materials present in the device. Combinations of these materials are described in detail in U.S. patent application Ser. No. 0132-0161 of U.S. 2016/0359122A1, the entire contents of which are incorporated herein by reference. The materials described or referenced therein are non-limiting examples of materials that may be used in combination with the compounds disclosed herein, and one skilled in the art can readily review the literature to identify other materials that may be used in combination.
Materials described herein as being useful for particular layers in an organic light emitting device can be used in combination with a variety of other materials present in the device. For example, the light emitting dopants disclosed herein may be used in conjunction with a variety of hosts, transport layers, barrier layers, injection layers, electrodes, and other layers that may be present. Combinations of these materials are described in detail in U.S. patent application Ser. No. US2015/0349273A1, paragraph 0080-0101, the entire contents of which are incorporated herein by reference. The materials described or referenced therein are non-limiting examples of materials that may be used in combination with the compounds disclosed herein, and one skilled in the art can readily review the literature to identify other materials that may be used in combination.
In the examples of material synthesis, all reactions were carried out under nitrogen unless otherwise stated. All reaction solvents were anhydrous and used as received from commercial sources. The synthesis product is subjected to structural validation and characterization using one or more equipment conventional in the art (including, but not limited to, Bruker's nuclear magnetic resonance apparatus, Shimadzu's liquid chromatograph-mass spectrometer, gas chromatograph-mass spectrometer, differential scanning calorimeter, Shanghai prism-based fluorescence spectrophotometer, Wuhan Corset's electrochemical workstation, Anhui Beidek's sublimator, etc.) in a manner well known to those skilled in the art. In an embodiment of the device, the device characteristics are also tested using equipment conventional in the art (including, but not limited to, an evaporator manufactured by Angstrom Engineering, an optical test system manufactured by Fushida, Suzhou, an ellipsometer manufactured by Beijing Mass., etc.) in a manner well known to those skilled in the art. Since the relevant contents of the above-mentioned device usage, testing method, etc. are known to those skilled in the art, the inherent data of the sample can be obtained with certainty and without being affected, and therefore, the relevant contents are not described in detail in this patent.
Materials synthesis example:
the preparation method of the compound of the present invention is not limited, and the following compounds are typically but not limited to, and the synthetic route and the preparation method thereof are as follows:
synthesis example 1: synthesis of Compound 81
Step 1: synthesis of intermediate 2
Figure BDA0003001663800000201
5g of starting material 1(24.03mmol) was dissolved in 50mL of DCM, 5.39g (1.3eq, 31.24mmol) of m-CPBA (m-chloroperoxybenzoic acid) was added at RT, stirred for 24h, TLC indicated disappearance of starting material, solvent was removed in vacuo and crude intermediate 2 was used directly in the next reaction.
And 2, step: synthesis of intermediate 3
Figure BDA0003001663800000202
Dissolving the intermediate 2 obtained in the step 1 in 24mL of phosphorus oxychloride, heating to 100 ℃, stirring for 3h, cooling to 0 ℃, slowly adding an aqueous solution of NaOH dropwise until the pH value is 9, extracting with DCM for three times (50mL of 3), combining organic phases, washing with a saturated aqueous solution of sodium chloride, drying over anhydrous magnesium sulfate, and removing the solvent in vacuum. Column chromatography (PE: EA ═ 30:1) gave 1.98g of intermediate 3 in 34% yield over two steps.
And step 3: synthesis of intermediate 5
Figure BDA0003001663800000203
3g (18.96mmol) of intermediate 4 are dissolved in 30mL of anhydrous tetrahydrofuran, the temperature is reduced to-78 ℃, n-BuLi (1M, 22.75mL) (1.2eq, 22.75mmol) is slowly added dropwise under nitrogen atmosphere, the temperature is raised to room temperature after the dropwise addition is finished, and the mixture is stirred for 1 h. The temperature was reduced to-78 ℃ and 4.63g (1.3eq, 24.65mmol) of 1, 2-dibromoethane was slowly added dropwise thereto, after the addition was complete, the mixture was warmed to room temperature and stirred overnight. The reaction was quenched with saturated ammonium chloride, extracted three times with EA (40mL x 3), the organic phases combined, washed with saturated aqueous sodium chloride solution, dried over anhydrous magnesium sulfate and the solvent removed in vacuo. Column chromatography (PE: EA ═ 100:1) gave 3.82g of intermediate 5 in 85% yield.
And 4, step 4: synthesis of intermediate 6
Figure BDA0003001663800000211
2.5g of intermediate 5(10.57mmol), 0.387g of PdCl2(dppf) (0.05eq, 0.53mmol), 1.56g of AcOK (1.5eq, 15.85mmol), 3.22g of B2Pin2(pinacol diboron) (1.2eq, 12.68mmol) was dissolved in 30mL of 1, 4-dioxane, heated to 80 ℃ and stirred overnight. Cooling to room temperature, removal of the solvent in vacuo and purification by column chromatography (PE: EA ═ 20:1) gave 2.21g of intermediate 6 as a white solid in 74% yield.
And 5: synthesis of intermediate 7
Figure BDA0003001663800000212
3.93g of intermediate 6(1.2eq, 13.85mmol), 2.78g of intermediate 3(1eq, 11.54mmol) and 0.387g of Pd (PPh)3)4(0.05eq,0.58mmol)、1.83g Na2CO3(1.5eq, 17.31mmol) was dissolved in 30mL of 1, 4-dioxane and 10mL of water, heated to 90 ℃ and stirred overnight. Cooling to room temperature, removal of the solvent in vacuo and purification by column chromatography (PE: EA ═ 50:1) gave 3g of intermediate 7 as a white solid in 72% yield.
Step 6: synthesis of intermediate 8
Figure BDA0003001663800000213
3.03g of intermediate 7(8.32mmol) are dissolved in 30mL of DCM, the temperature is reduced to 0 ℃, and BBr is slowly added dropwise under nitrogen atmosphere3Stirred for 2h, NaHCO3The reaction was quenched with aqueous solution, extracted with DCM (60mL x 3), the organic phases combined, washed with saturated aqueous sodium chloride, dried over anhydrous magnesium sulphate and the solvent removed in vacuo. Column chromatography (PE: EA ═ 4:1) gave 1.17g of intermediate 8 in 40% yield.
And 7: synthesis of intermediate 9
Figure BDA0003001663800000214
1.2g of intermediate 8(1eq, 3.33mmol), 24mg of CuBr (0.05eq, 0.17mmol) and 2.82g of K were added3PO4(4eq, 13.3mmol) was dissolved in 15mL of DMF, heated to 90 ℃ and stirred overnight. Cool to room temperature, dilute with water, precipitate, filter through celite, and wash the solid with 1L of DCM. Yield 0.81g of intermediate 9 was obtained in 90% yield. The resulting yellow solid intermediate 9 was recrystallized from toluene to give a solid intermediate 9 having a purity of 99.7%.
And 8: synthesis of Iridium dimer
Figure BDA0003001663800000221
1.2g (3eq, 4.45mmol) of intermediate 9 were dissolved in 24mL of 2-ethoxyethanol and 8mL of water at room temperature, and 523mg of IrCl was added3·3H2O (1eq, 1.48mmol), was ventilated three times at room temperature, heated to 130 ℃ and refluxed at this temperature for 24 hours, and cooled to room temperature. And (3) filtering, washing the solid with ethanol until the washing liquid is colorless, and performing suction filtration for about 15 minutes until the ethanol on the solid completely disappears to obtain 1.13g of red solid iridium dimer, wherein the yield is 99%, and the red solid iridium dimer is directly used for the next reaction without purification.
And step 9: synthesis of Compound 81
Figure BDA0003001663800000222
1.13g of the iridium dimer (1eq, 0.74mmol) obtained in step 8 was charged to a 100mL round-bottomed flask, and 510mg of K was added2CO3(5eq, 3.7mmol) and 0.74g of 3, 7-diethyl-3-methyl-4, 6-nonanedione (4eq, 2.96mmol) were replaced with nitrogen at room temperature three times, stirred under nitrogen for 24 hours, filtered through celite, and the solid was washed with ethanol until the wash was colorless, filtered with suction for about 15 minutes, and the ethanol adsorbed on the solid was removed. The red solid on top of the celite was dissolved in 200mL of dichloromethane with vacuum filtration, 20mL of ethanol was added to the flask, dichloromethane was removed in vacuo, the product precipitated in the remaining ethanol, filtered and the solid adsorbed ethanol was drained. Purification by silica gel column chromatography (PE: DCM ═ 10:1), dissolving the crude solid in 200mL of dichloromethane, adding 20mL of ethanol, removing dichloromethane in vacuo, precipitating the product in the remaining ethanol, filtering, and drying the ethanol adsorbed on the solid to obtain compound 81 as a red solid (mass 1.13g, yield 80%). The purity is 99.6%. The product was identified as the target product, molecular weight 954.3.
Synthesis example 2: synthesis of Compound 83
Step 1: synthesis of intermediate 11:
Figure BDA0003001663800000223
intermediate 10(7.6g,35.1mmol) was dissolved in 70mL of ultra-dry tetrahydrofuran, then the reaction was cooled to 0 ℃, then an n-butyllithium solution (15.5mL, 38.7mmol) was added dropwise thereto under nitrogen, the temperature was kept for 1h after completion of the dropwise addition, then isopropanol pinacol borate (iPrOBpin, 8.49g, 45.6mmol) was added thereto, the reaction was allowed to warm to room temperature for 2h after completion of the addition, and then a saturated ammonium chloride solution was added thereto to quench the reaction. Ethyl acetate was then added to the reaction, the layers were separated, the aqueous phase was extracted with ethyl acetate, the organic phases were combined, dried and spin-dried to give a crude product, which was separated by silica gel column chromatography (eluent ethyl acetate: petroleum ether: 1:50, v/v) to give the desired product, intermediate 11(4.7g, 39.1%) as a colorless oily liquid.
Step 2: synthesis of intermediate 13:
Figure BDA0003001663800000224
intermediate 12(3.19g,13.7mmol), intermediate 11(4.7g,13.7mmol), tetrakistriphenylphosphine palladium (0.8g, 0.69mmol), sodium carbonate (2.18g, 20.55mmol), 1, 4-dioxane (60mL) and water (15mL) were added to a 250mL round bottom flask, and the reaction was heated to 80 ℃ under nitrogen blanket and stirred overnight, cooled to room temperature after TLC indicated completion of the reaction. Ethyl acetate was then added to the reaction, the layers were separated, the aqueous phase was extracted with ethyl acetate, the organic phases were combined, dried and spin-dried to give a crude product, which was separated by silica gel column chromatography (eluent ethyl acetate: petroleum ether ═ 1:10, v/v) to give intermediate 13(3.5g, 73.0%) as a white solid as the desired product.
And 3, step 3: synthesis of intermediate 14:
Figure BDA0003001663800000231
intermediate 13(4.1g,10mmol) was dissolved in 20mL of ethanol, followed by the addition of 2M HCl 20mL thereto, then the reaction was heated to reflux with stirring overnight and cooled to room temperature after TLC showed completion of the reaction. Then, saturated sodium carbonate solution was added thereto to adjust the pH to neutral, and a large amount of yellow solid was precipitated in the solution, which was filtered, washed several times with water, and then drained to obtain the objective product, intermediate 14(3.3g, 93.2%) as a yellow solid.
And 4, step 4: synthesis of intermediate 15:
Figure BDA0003001663800000232
intermediate 14(3.3g,9.3mmol), cuprous bromide (133mg, 0.9mmol), 2,2,6, 6-tetramethylheptanedione (1.37g, 7.44mmol), cesium carbonate (7.6g, 23.25mmol) and DMF (90mL) were heated to 135 ℃ under nitrogen blanket for reaction overnight, and cooled to room temperature after TLC indicated completion of the reaction. 200mL of water was added to the reaction solution until a large amount of yellow solid precipitated out, and the solid was filtered, washed with water several times and then drained to obtain the desired product, intermediate 15(3.10g, 96%) as a yellow solid.
And 5: synthesis of intermediate 16:
Figure BDA0003001663800000233
intermediate 15(3.42g,10.8mmol), isobutylboronic acid (2.2g, 21.6mmol), palladium acetate (121mg, 0.54mmol), Sphos (443mg, 1.08mmol), potassium phosphate trihydrate (8.63g, 32.4mmol) and toluene (80mL) were heated to reflux under nitrogen overnight and cooled to room temperature after TLC showed completion of the reaction. The crude product was separated by silica gel column chromatography (eluent ethyl acetate: petroleum ether 1:30, v/v) to give the desired product, intermediate 16(1.8g, 49.4%), as a yellow solid.
Step 6: synthesis of iridium dimer:
Figure BDA0003001663800000241
a mixture of intermediate 16(1.8g, 5.3mmol), iridium trichloride trihydrate (628mg, 1.78mmol), 2-ethoxyethanol (21mL) and water (7mL) was refluxed under nitrogen for 24 hours. After cooling to room temperature, the water was carefully removed from the solution by rotary evaporation to give a solution of dimer in ethoxyethanol, which was used in the next reaction without further purification.
And 7: synthesis of Compound 83
Figure BDA0003001663800000242
A solution of iridium dimer, 3.7-diethyl-3-methylnonane-4, 6-dione (663mg, 2.67mmol) and potassium carbonate (1.23g, 8.9mmol) were charged into a 100mL round-bottomed flask and reacted at 60 ℃ for 24 hours under nitrogen. It was then poured into a funnel with celite, filtered and washed with ethanol. Methylene chloride was added to the resulting solid and the filtrate was collected. Ethanol was then added and the resulting solution was concentrated, but not dried. After filtration 1.1g of the product compound 83 is obtained, yield 57%. The product was further purified by column chromatography. The structure of the compound was confirmed by NMR and LC-MS to be the target product, molecular weight 1094.5.
Synthetic example 3: synthesis of Compound 64
Step 1: synthesis of intermediate 18
Figure BDA0003001663800000243
Intermediate 17(2.93g, 12.54mmol), intermediate 11(3.9g, 11.4mmol), Pd (dppf) Cl2(439mg, 0.6mmol) and K2CO3(4.73g, 34.2mmol) was mixed with dioxane/water (42mL/14mL), and after replacement of nitrogen, the reaction was allowed to proceed overnight at room temperature. After filtration through celite, EA was added thereto and extracted three times, the organic phases were combined, concentrated and subjected to column chromatography to give intermediate 18(3g, yield 63.7%).
Step 2: synthesis of intermediate 20
Figure BDA0003001663800000244
Intermediate 18(3.8g, 9.2mmol) was added to a mixture of 12N HCl (7.6mL) and MeOH (20mL) and reacted at 54 deg.C for 2 hours, after completion of the TLC check, cooled to room temperature, to which saturated NaHCO was added3The Ph of the solution was adjusted to about 7-8, extracted three times with EA, the organic phases were combined, washed with saturated aqueous sodium chloride solution and concentrated to give the crude intermediate 19, which was used directly in the next reaction without further purification. The crude intermediate 19 (2.6g, 7.2mmol), CuBr (103mg, 0.72mmol), 22,6, 6-tetramethyl-3, 5-heptanedione (1.06g, 5.76mmol) and Cs2CO3(5.87g, 18mmol) was mixed in DMF (72mL) and after displacement of nitrogen, the reaction was allowed to proceed overnight, cooled to room temperature and the product was filtered off, the filter cake was washed with appropriate amount of DMF and then EtOH and PE, and dried to give intermediate 20(1.85g, 63% over two steps).
And step 3: synthesis of intermediate 21
Figure BDA0003001663800000251
Intermediate 20(1.85g, 5.82mmol), isobutylboronic acid (1.19g, 11.64mmol), Pd (OAc)2(65mg, 0.29mmol), sphos (238mg, 0.58mmol) and K3PO4·3H2O (4.66g, 17.5mmol) was mixed in toluene (58mL) and the reaction refluxed at 120 ℃ under nitrogen. After the intermediate 21 was completely converted by HPLC, it was cooled to room temperature, and the reaction solution was filtered through celite, concentrated and subjected to column chromatography to give intermediate 21(1.3g of yellow solid, yield 66%).
And 4, step 4: synthesis of compound 64:
Figure BDA0003001663800000252
intermediate 21(825mg,2.42mmol), IrCl3·3H2O (286mg, 0.81mmol), ethoxyethanol (11.5mL) and water (3.5mL) were weighed into a 100mL single-neck flask, replaced with nitrogen, reacted at 130 ℃ under reflux for 24 hours, after the reaction cooled to room temperature, the resulting precipitate was filtered off, the filter cake was washed with ethanol and dried, and the resulting iridium dimer was reacted with 3, 7-diethyl-1, 1, 1-trifluorononane-4, 6-dione (319mg,1.2mmol), K2CO3(560mg, 4.05mmol) and ethoxyethanol (13mL) were mixed in a 100mL single-necked flask, and after replacement of nitrogen, the reaction was allowed to proceed overnight at room temperature, and after completion of the reaction was monitored by TLC, the stirring was stopped. The reaction solution was filtered through celite, the filter cake was washed with a suitable amount of EtOH, the crude product was washed with DCM into a 250mL eggplant-shaped bottle, EtOH (about 5mL) was added thereto, DCM was removed by swirling at room temperature, and a solid was seenPrecipitated, which was filtered off and washed with an appropriate amount of EtOH to give compound 64(80mg, yield 8.7%) as a product. The product was identified as the target product, molecular weight 1136.4.
Synthetic example 4: synthesis of Compound 93
Step 1: synthesis of iridium dimer:
Figure BDA0003001663800000253
a mixture of intermediate 22(0.76g, 1.92mmol), iridium trichloride trihydrate (226mg, 0.64mmol), 2-ethoxyethanol (7.5mL) and water (2.5mL) was refluxed under nitrogen for 24 hours. After cooling to room temperature, the water in the solution was carefully removed by rotary evaporation to give an ethoxyethanol solution of iridium dimer, which was used in the next reaction without further purification.
Step 2: synthesis of Compound 93
Figure BDA0003001663800000261
The iridium dimer solution in ethoxyethanol obtained in the previous step, 3.7-diethyl-3-methylnonane-4, 6-dione (450mg, 1.84mmol) and potassium carbonate (0.64g, 4.45mmol) were added to a 25mL round-bottomed flask and reacted at 50 ℃ for 24 hours under nitrogen. It was then poured into a funnel with celite, filtered and washed with ethanol. Methylene chloride was added to the resulting solid and the filtrate was collected. Ethanol was then added and the resulting solution was concentrated, but not dried. After filtration 550mg of the product compound 93 is obtained with a yield of 71%. The structure of the compound was confirmed by LC-MS to be the target product, molecular weight 1206.6.
Synthesis example 5: synthesis of Compound 117
Step 1: synthesis of iridium dimer:
Figure BDA0003001663800000262
intermediate 23(2.1g,5.56mmol), iridium trichloride trihydrate (494mg, 1.4mmol), ethoxyethanol (18mL) and water (6mL) were weighed into a 250mL single neck flask, nitrogen was replaced, the reaction was refluxed at 130 ℃ for 24 hours, after the reaction was cooled to room temperature, the resulting precipitate was filtered off, the filter cake was washed with ethanol and dried to obtain iridium dimer, which was used directly in the next reaction without further purification.
And 2, step: synthesis of compound 117:
Figure BDA0003001663800000263
the iridium dimer thus obtained was mixed with 3, 7-diethyl-3, 7-dimethyl-4, 6-nonanedione (421mg, 1.75mmol), potassium carbonate (1.94mg, 14mmol) and ethoxyethanol (24mL) in a 100mL single-necked flask, and after replacement of nitrogen, the reaction was carried out overnight at 55 ℃ while the stirring was stopped after completion of the TLC monitoring. Filtering the reaction solution by using diatomite, washing a filter cake by using a proper amount of ethanol, washing a crude product into a 250mL eggplant-shaped bottle by using dichloromethane, adding ethanol (about 5mL) into the eggplant-shaped bottle, carrying out rotary evaporation at normal temperature to remove dichloromethane, thus obtaining a solid which is separated out, filtering the solid, washing the solid by using a proper amount of ethanol, drying the solid, dissolving the solid in dichloromethane, and carrying out column chromatography after concentration to obtain a red solid compound 117(1g, the yield is 60%) with the purity of 99.4%. The structure of the compound was confirmed by LC-MS to be the target product, molecular weight 1192.6.
Synthetic example 6: synthesis of Compound 116
Step 1: synthesis of iridium dimer:
Figure BDA0003001663800000264
a mixture of intermediate 24(1.37g, 3.73mmol), iridium trichloride trihydrate (329mg, 0.93mmol), 2-ethoxyethanol (12mL) and water (4mL) was refluxed under nitrogen for 24 hours. After cooling to room temperature, red solid iridium dimer was obtained by filtration and used in the next reaction without further purification.
Step 2: synthesis of compound 116:
Figure BDA0003001663800000271
the iridium dimer obtained in the previous step, 3.7-diethyl-3, 7-dimethylnonane-4, 6-dione (430mg, 1.79mmol) and potassium carbonate (0.62g, 4.48mmol) were charged into a 50mL round-bottomed flask and reacted at 50 ℃ for 24 hours under nitrogen. It was then poured into a funnel with celite, filtered and washed with ethanol. Methylene chloride was added to the resulting solid and the filtrate was collected. Ethanol was then added and the resulting solution was concentrated, but not dried. After filtration 810mg of the product compound 116 are obtained in 82.2% yield. The structure of the compound was confirmed by LC-MS to be the target product, molecular weight 1164.5.
Synthetic example 7: synthesis of Compound 261
Step 1: synthesis of iridium dimer:
Figure BDA0003001663800000272
a mixture of intermediate 25(0.76g, 1.92mmol), iridium trichloride trihydrate (226mg, 0.64mmol), 2-ethoxyethanol (7.5mL) and water (2.5mL) was refluxed under nitrogen for 24 hours. After cooling to room temperature, the water in the solution was carefully removed by rotary evaporation to give an ethoxyethanol solution of iridium dimer, which was used in the next reaction without further purification.
Step 2: synthesis of compound 261:
Figure BDA0003001663800000273
the iridium dimer solution in ethoxyethanol obtained in the above step, 3, 7-diethyl-3, 7-dimethylnonane-4, 6-dione (450mg, 1.84mmol) and potassium carbonate (0.64g, 4.45mmol) were added to a 25mL round-bottomed flask and reacted at 50 ℃ for 24 hours under nitrogen. It was then poured into a funnel with celite, filtered and washed with ethanol. Methylene chloride was added to the resulting solid and the filtrate was collected. Ethanol was then added and the resulting solution was concentrated, but not dried. After filtration, 1.75g of product compound 261 are obtained, yield 96%. The structure of the compound was confirmed by LC-MS to be the target product, molecular weight 1220.6.
Synthesis example 8: synthesis of Compound 262
Step 1: synthesis of iridium dimer:
Figure BDA0003001663800000274
a mixture of intermediate 26(0.76g, 1.92mmol), iridium trichloride trihydrate (226mg, 0.64mmol), 2-ethoxyethanol (7.5mL) and water (2.5mL) was refluxed under nitrogen for 24 hours. After cooling to room temperature, the water in the solution was carefully removed by rotary evaporation to give an ethoxyethanol solution of iridium dimer, which was used in the next reaction without further purification.
Step 2: synthesis of compound 262:
Figure BDA0003001663800000281
the iridium dimer in ethoxyethanol solution obtained in the above step, 3.7-diethyl-1, 1, 1-trifluorononane-4, 6-dione (450mg, 1.84mmol) and potassium carbonate (0.64g, 4.45mmol) were charged in a 25mL round-bottomed flask and reacted at 50 ℃ for 24 hours under nitrogen. It was then poured into a funnel with celite, filtered and washed with ethanol. Methylene chloride was added to the resulting solid and the filtrate was collected. Ethanol was then added and the resulting solution was concentrated, but not dried. After filtration, 1.35g of the product compound 262 is obtained, with a purity of 98.86% and a yield of 92%. The structure of the compound was confirmed by LC-MS to be the target product, molecular weight 1246.5.
Synthetic example 9: synthesis of Compound 264
Step 1: synthesis of iridium dimer:
Figure BDA0003001663800000282
intermediate 27(800mg,2.1mmol), iridium trichloride trihydrate (250mg, 0.7mmol), ethoxyethanol (7.5mL) and water (2.5mL) were charged into a 100mL single-neck flask, nitrogen was replaced, the reaction was refluxed at 130 ℃ for 24 hours, after the reaction was cooled, the solvent was concentrated and dried by spinning to obtain an iridium dimer, which was used in the next reaction without further purification.
And 2, step: synthesis of compound 264:
Figure BDA0003001663800000283
adding 3, 7-diethyl-3, 7-dimethylnonane-4, 6-dione (337mg, 1.4mmol), potassium carbonate (967mg, 7mmol) and ethoxyethanol (14mL) into the iridium dimer obtained in the above step, replacing nitrogen, reacting at room temperature for 48 hours, filtering the reaction solution with diatomaceous earth, washing the filter cake with an appropriate amount of ethanol, washing the crude product with dichloromethane into a 250mL eggplant-shaped bottle, adding ethanol (about 5mL) into the bottle, removing dichloromethane by rotary evaporation at room temperature to obtain a solid, filtering out the solid, washing with an appropriate amount of ethanol again, drying, dissolving in dichloromethane, concentrating, and purifying by column chromatography to obtain compound 264(570 mg). The structure of the compound was confirmed by LC-MS to be the target product, molecular weight 1192.6.
Synthetic example 10: synthesis of Compound 263
Step 1: synthesis of iridium dimer:
Figure BDA0003001663800000284
a mixture of intermediate 28(0.46g, 1.28mmol), iridium trichloride trihydrate (130mg, 0.37mmol), 2-ethoxyethanol (4.5mL) and water (1.5mL) was refluxed under nitrogen for 24 hours. After cooling to room temperature, red solid iridium dimer was obtained by filtration and used in the next reaction without further purification.
Step 2: synthesis of compound 263:
Figure BDA0003001663800000291
the iridium dimer obtained in the previous step, 3.7-diethyl-3, 7-dimethylnonane-4, 6-dione (133mg, 0.55mmol) and potassium carbonate (0.25g, 1.84mmol) were charged into a 50mL round-bottomed flask and reacted at 40 ℃ for 24 hours under nitrogen. It was then poured into a funnel with celite, filtered and washed with ethanol. Methylene chloride was added to the resulting solid and the filtrate was collected. Ethanol was then added and the resulting solution was concentrated, but not dried. After filtration, 300mg of product compound 263 is obtained, yield 73.7%. The structure of the compound was confirmed by LC-MS to be the target product, molecular weight 1164.5.
Synthetic example 11: synthesis of Compound 266
Step 1: synthesis of iridium dimer:
Figure BDA0003001663800000292
a mixture of intermediate 29(1.45g, 3.42mmol), iridium trichloride trihydrate (346mg, 0.98mmol), 2-ethoxyethanol (12mL) and water (4mL) was refluxed under nitrogen for 24 hours. After cooling to room temperature, red solid iridium dimer was obtained by filtration and used in the next reaction without further purification.
Step 2: synthesis of compound 266:
Figure BDA0003001663800000293
the iridium dimer (0.67g, 0.31mmol), 3, 7-diethyl-3-methylnonane-4, 6-dione (0.21g, 0.94mmol) and potassium carbonate (0.43g, 3.1mmol) obtained in the previous step were dissolved in 9mL of ethoxyethanol and reacted at 40 ℃ for 24 hours under nitrogen. It was then poured into a funnel with celite, filtered and washed with ethanol. Methylene chloride was added to the resulting solid and the filtrate was collected. Ethanol was then added and the resulting solution was concentrated, but not dried. After filtration, 370mg of compound 266 were obtained in 47.3% yield. The structure of the compound was confirmed by LC-MS to be the target product, molecular weight 1262.6.
Synthetic example 12: synthesis of Compound 265
Step 1: synthesis of compound 265:
Figure BDA0003001663800000294
iridium dimer (0.67g, 0.31mmol), intermediate 30(0.21g, 0.94mmol) and potassium carbonate (0.43g, 3.1mmol) were dissolved in 9mL of ethoxyethanol and reacted at 40 ℃ for 24 hours under nitrogen. It was then poured into a funnel with celite, filtered and washed with ethanol. Methylene chloride was added to the resulting solid and the filtrate was collected. Ethanol was then added and the resulting solution was concentrated, but not dried. After filtration 370mg of compound 265 are obtained with a yield of 47.3%. The structure of the compound was confirmed by LC-MS to be the target product, molecular weight 1302.6.
Synthetic example 13: synthesis of Compound 267
Step 1: synthesis of iridium dimer:
Figure BDA0003001663800000301
a mixture of intermediate 31(0.6g, 1.68mmol), iridium trichloride trihydrate (198mg, 0.56mmol), 2-ethoxyethanol (7.5mL) and water (2.5mL) was refluxed under nitrogen for 24 hours. After cooling to room temperature, red solid iridium dimer was obtained by filtration and used in the next reaction without further purification.
And 2, step: synthesis of compound 267:
Figure BDA0003001663800000302
the iridium dimer obtained in the above step, 3, 7-diethyl-3, 7-dimethylnonane-4, 6-dione (270mg, 1.12mmol) and potassium carbonate (0.77g, 5.6mmol) were charged into a 25mL round-bottomed flask and reacted at 50 ℃ for 24 hours under nitrogen. It was then poured into a funnel with celite, filtered and washed with ethanol. Methylene chloride was added to the resulting solid and the filtrate was collected. Ethanol was then added and the resulting solution was concentrated, but not dried. After filtration, 0.4g of crude product is obtained, 91.6% pure, which is further purified by column chromatography to yield 0.3g of the final product compound 267 in 47% yield. The structure of the compound was confirmed by LC-MS to be the target product, molecular weight 1136.5.
Synthesis example 14: synthesis of Compound 269
Step 1: synthesis of Iridium dimer
Figure BDA0003001663800000303
A mixture of intermediate 32(1.5g, 4.2mmol), iridium trichloride trihydrate (427mg, 1.2mmol), 2-ethoxyethanol (12mL) and water (4mL) was refluxed under nitrogen for 24 hours. After cooling to room temperature, red solid iridium dimer was obtained by filtration and used in the next reaction without further purification.
Step 2: synthesis of Compound 269
Figure BDA0003001663800000304
The iridium dimer obtained in the previous step, 3, 7-diethyl-3, 7-dimethylnonane-4, 6-dione (580mg, 2.4mmol) and potassium carbonate (0.83g, 6.04mmol) were dissolved in 16mL of ethoxyethanol and reacted at 40 ℃ for 24 hours under nitrogen. It was then poured into a funnel with celite, filtered and washed with ethanol. Methylene chloride was added to the resulting solid and the filtrate was collected. Ethanol was then added and the resulting solution was concentrated, but not dried. After filtration 940mg of compound 269 are obtained in 66% yield. The structure of the compound was confirmed by LC-MS to be the target product, molecular weight 1166.5.
Synthetic example 15: synthesis of Compound 288
Step 1: synthesis of iridium dimer:
Figure BDA0003001663800000311
a mixture of intermediate 33(1.2g,2.93mmol), iridium trichloride trihydrate (427mg, 1.2mmol), 2-ethoxyethanol (12mL) and water (4mL) was refluxed under nitrogen for 24 hours. After cooling to room temperature, red solid iridium dimer was obtained by filtration and used in the next reaction without further purification.
Step 2: synthesis of compound 288:
Figure BDA0003001663800000312
the iridium dimer (0.67g, 0.31mmol) obtained in the previous step, intermediate 34(414mg, 1.76mmol) and sodium hydroxide (176mg, 4.4mmol) were dissolved in 16mL of ethoxyethanol and reacted at 40 ℃ for 24 hours under nitrogen. It was then poured into a funnel with celite, filtered and washed with ethanol. Methylene chloride was added to the resulting solid and the filtrate was collected. Ethanol was then added and the resulting solution was concentrated, but not dried. After filtration 410mg of compound 288 are obtained with a yield of 27.4%. The structure of the compound was confirmed by LC-MS to be the target product, molecular weight 1248.6.
Synthetic example 16: synthesis of Compound 273
Step 1: synthesis of iridium dimer:
Figure BDA0003001663800000313
a mixture of intermediate 35(1.3g, 3.54mmol), iridium trichloride trihydrate (204mg, 0.58mmol), 2-ethoxyethanol (18mL) and water (6mL) was refluxed under nitrogen for 24 hours. After cooling to room temperature, red solid iridium dimer was obtained by filtration and used in the next reaction without further purification.
Step 2: synthesis of compound 273:
Figure BDA0003001663800000314
the iridium dimer obtained in the above step, 3, 7-diethyl-3, 7-dimethylnonane-4, 6-dione (0.21g, 0.87mmol) and potassium carbonate (0.40g, 2.9mmol) were charged into a 100mL round-bottomed flask and reacted at 50 ℃ for 24 hours under nitrogen. It was then poured into a funnel with celite, filtered and washed with ethanol. Methylene chloride was added to the resulting solid and the filtrate was collected. Ethanol was then added and the resulting solution was concentrated, but not dried. After filtration 0.7g of crude product is obtained, which is further purified by column chromatography to yield 0.6g of compound 273 in 91% yield. The structure of the compound was confirmed by LC-MS to be the target product, molecular weight 1136.5.
Synthetic example 17: synthesis of Compound 282
Step 1: synthesis of iridium dimer:
Figure BDA0003001663800000321
a mixture of intermediate 36(1.77g,3.87mmol), iridium trichloride trihydrate (390mg, 1.11mmol), 2-ethoxyethanol (24mL) and water (8mL) was refluxed under nitrogen for 24 hours. After cooling to room temperature, red solid iridium dimer was obtained by filtration and used in the next reaction without further purification.
Step 2: synthesis of compound 282:
Figure BDA0003001663800000322
the iridium dimer obtained in the above step, 3, 7-diethyl-3, 7-dimethylnonane-4, 6-dione (0.4g, 1.66mmol) and potassium carbonate (0.77mg, 5.6mmol) were charged into a 100mL round-bottomed flask and reacted at 50 ℃ for 48 hours under nitrogen. It was then poured into a funnel with celite, filtered and washed with ethanol. Methylene chloride was added to the resulting solid and the filtrate was collected. Ethanol was then added and the resulting solution was concentrated, but not dried. After filtration, 0.7g of crude product is obtained, which is further purified by column chromatography to yield 0.25g of compound 282 in 17% yield. The structure of the compound was confirmed by LC-MS to be the target product, molecular weight 1344.6.
Synthetic example 18: synthesis of Compound 287
Step 1: synthesis of compound 287:
Figure BDA0003001663800000323
iridium dimer (0.94g, 0.45mmol), 3, 7-diethyl-3, 7-dimethylnonane-4, 6-dione (0.32g, 1.34mmol) and potassium carbonate (0.62mg, 4.45mmol) were dissolved in 25mL of ethoxyethanol and reacted at 40 ℃ for 24 hours under nitrogen. It was then poured into a funnel with celite, filtered and washed with ethanol. Methylene chloride was added to the resulting solid and the filtrate was collected. Ethanol was then added and the resulting solution was concentrated, but not dried. After filtration, 0.87g of compound 287 is obtained in 78% yield. The structure of the compound was confirmed by LC-MS to be the target product, molecular weight 1248.6.
Synthetic example 19: synthesis of Compound 291
Step 1: synthesis of intermediate 38
Figure BDA0003001663800000331
Intermediate 37(2.68g, 8.69mmol), TMEDA (1.31g, 11.3mmol) were dissolved in 80mL of ultra dry THF, the reaction was cooled to 0 deg.C, then n-butyllithium (4.2mL, 10.43mmol, 2.5M) was added slowly and after 1h of reaction at this temperature, isopropanol pinacol borate (2.102g, 11.3mmol) was added and reacted overnight, after TLC showed completion of the reaction, saturated ammonium chloride was added to quench the reaction, EA was extracted, dried, filtered and evaporated to remove the solvent to give crude product which was purified by silica gel column chromatography to give intermediate 38(3.86g, 82%).
Step 2: synthesis of intermediate 39
Figure BDA0003001663800000332
Intermediate 12(1.95g, 8.4mmol), intermediate 38(3.85g, 8.4mmol), Pd (PPh)3)4A mixture of (0.48g, 0.42mmol), sodium carbonate (1.34g, 12.6mmol) and 1, 4-dioxane/water (32mL/8mL) was heated to reflux under nitrogen overnight and cooled to room temperature after TLC indicated completion of the reaction. Water was added to the reaction, EA was used to extract the organic phase, which was dried, filtered and the solvent removed by rotary evaporation to give intermediate 39(3.1g, yield 70%).
And step 3: synthesis of intermediate 40
Figure BDA0003001663800000333
Intermediate 39(3.1g, 5.91mmol) was dissolved in 15mL ethanol, then 15mL HCl (2N) was slowly added to the reaction system, then heated to reflux, reacted for 2h, cooled to room temperature after TLC showed completion of the reaction, neutralized to neutral by addition of sodium bicarbonate solution, filtered to give crude solid, purified by column chromatography to give intermediate 40(2.75g, 99.78% yield).
And 4, step 4: synthesis of intermediate 41
Figure BDA0003001663800000334
Intermediate 40(2.75g, 5.9mmol), cuprous bromide (86mg, 0.6mmol), 2,2,6, 6-tetramethylheptanedione (0.88g, 4.8mmol), cesium carbonate (4.89g, 15mmol) and DMF (60mL) were heated to 135 ℃ under nitrogen blanket for reaction overnight, and cooled to room temperature after TLC indicated completion of the reaction. Water was added thereto until a large amount of yellow solid precipitated in the solution, which was filtered, washed several times with water and then dried by suction to obtain intermediate 41(2.54g, yield 99.8%) as a yellow solid.
And 5: synthesis of intermediate 42
Figure BDA0003001663800000341
Intermediate 41(2.54g, 5.91mmol), neopentyl boronic acid (1.37g, 11.83mmol), Pd2(dba)3(135mg,0.15mmol),Sphos(243mg,0.59mmol),K3PO4.3H2O (4.72g, 17.7mmol) and toluene 30mL are mixed, the system is vacuumized and nitrogen exchanged for three times, the mixture is heated to reflux and reacted overnight, TLC detects the reaction to be complete and then cooled to room temperature, solvent is removed by rotary evaporation to obtain crude product, and the crude product is purified by column chromatography to obtain intermediate 42(1.8g, yield 65%).
Step 6: synthesis of iridium dimer:
Figure BDA0003001663800000342
a mixture of intermediate 42(1.4g,3.0mmol), iridium trichloride trihydrate (0.35g, 1.0mmol), 2-ethoxyethanol (12mL) and water (4mL) was refluxed under nitrogen for 24 hours. After cooling to room temperature, red solid iridium dimer was obtained by filtration and used in the next reaction without further purification.
And 7: synthesis of compound 291:
Figure BDA0003001663800000343
the iridium dimer obtained in the previous step, 3.7-diethyl-1, 1, 1-trifluorononane-4, 6-dione (0.39g, 1.5mmol) and potassium carbonate (0.69g, 5.00mmol) were dissolved in 16mL of ethoxyethanol and reacted at 50 ℃ for 24 hours under nitrogen. It was then poured into a funnel with celite, filtered and washed with ethanol. Methylene chloride was added to the resulting solid and the filtrate was collected. Ethanol was then added and the resulting solution was concentrated, but not dried. After filtration, 0.71g of compound 291 was obtained in 41.2% yield. The structure of the compound was confirmed by LC-MS to be the target product, molecular weight 1386.7.
Synthesis example 20: synthesis of Compound 292
Step 1: synthesis of iridium dimer:
Figure BDA0003001663800000344
a mixture of intermediate 43(1.4g,2.92mmol), iridium trichloride trihydrate (0.34g, 0.97mmol), 2-ethoxyethanol (12mL) and water (4mL) was refluxed under nitrogen for 24 hours. After cooling to room temperature, red solid iridium dimer was obtained by filtration and used in the next reaction without further purification.
Step 2: synthesis of compound 292:
Figure BDA0003001663800000351
the iridium dimer obtained in the previous step, 3.7-diethyl-1, 1, 1-trifluorononane-4, 6-dione (0.38g, 1.5mmol) and potassium carbonate (0.67g, 4.85mmol) were dissolved in 16mL of ethoxyethanol and reacted at 50 ℃ for 24 hours under nitrogen. It was then poured into a funnel with celite, filtered and washed with ethanol. Methylene chloride was added to the resulting solid and the filtrate was collected. Ethanol was then added and the resulting solution was concentrated, but not dried. After filtration, 0.67g of compound 292 was obtained in 49% yield. The structure of the compound was confirmed by LC-MS to be the target product, molecular weight 1414.7.
Synthetic example 21: synthesis of Compound 293
Step 1: synthesis of compound 293:
Figure BDA0003001663800000352
iridium dimer (1.01g, 0.97mmol), 3,3, 7-triethylnonane-4, 6-dione (0.4g, 1.5mmol) and potassium carbonate (0.72g, 4.85mmol) were dissolved in 16mL of ethoxyethanol and reacted at 50 ℃ for 24 hours under nitrogen. It was then poured into a funnel with celite, filtered and washed with ethanol. Methylene chloride was added to the resulting solid and the filtrate was collected. Ethanol was then added and the resulting solution was concentrated, but not dried. After filtration, 0.62g of compound 293 is obtained in 45% yield. The structure of the compound was confirmed by LC-MS to be the target product, molecular weight 1388.8.
Synthetic example 22: synthesis of Compound 294
Step 1: synthesis of iridium dimer:
Figure BDA0003001663800000353
a mixture of intermediate 44(0.68g,1.60mmol), iridium trichloride trihydrate (0.16g, 0.45mmol), 2-ethoxyethanol (6mL) and water (2mL) was refluxed under nitrogen for 24 hours. After cooling to room temperature, red solid iridium dimer was obtained by filtration and used in the next reaction without further purification.
Step 2: synthesis of compound 294:
Figure BDA0003001663800000354
the iridium dimer obtained in the previous step, 3, 7-diethyl-3, 7-dimethylnonane-4, 6-dione (0.22g, 0.9mmol) and potassium carbonate (0.62g, 4.5mmol) were dissolved in 16mL of ethoxyethanol and reacted at 50 ℃ for 24 hours under nitrogen. It was then poured into a funnel with celite, filtered and washed with ethanol. Methylene chloride was added to the resulting solid and the filtrate was collected. Ethanol was then added and the resulting solution was concentrated, but not dried. After filtration, 0.42g of compound 294 is obtained in 73% yield. The structure of the compound was confirmed by LC-MS to be the target product, molecular weight 1276.7.
Synthetic example 23: synthesis of Compound 295
Step 1: synthesis of iridium dimer:
Figure BDA0003001663800000361
a mixture of intermediate 45(2.03g,4.93mmol), iridium trichloride trihydrate (0.48g, 1.37mmol), 2-ethoxyethanol (33mL) and water (11mL) was refluxed under nitrogen for 24 hours. After cooling to room temperature, red solid iridium dimer was obtained by filtration and used in the next reaction without further purification.
Step 2: synthesis of compound 295:
Figure BDA0003001663800000362
the iridium dimer obtained in the previous step, 3, 7-diethyl-1, 1, 1-trifluorononane-4, 6-dione (0.53g, 2mmol) and potassium carbonate (0.95g, 6.85mmol) were mixed with ethoxyethanol (23mL), and the mixture was reacted at room temperature for 48 hours while displacing nitrogen. The reaction solution was filtered through celite, the filter cake was washed with appropriate amount of EtOH, the crude product was washed with DCM to 250mL eggplant-shaped bottle, EtOH (about 10mL) was added thereto, DCM was removed by rotary evaporation at room temperature, solid was precipitated, the crude product was filtered and washed with appropriate amount of EtOH to obtain crude product, which was purified by column chromatography to obtain 0.1g of compound 295 with yield 5.7%. The structure of the compound was confirmed by LC-MS to be the target product, molecular weight 1278.5.
Synthetic example 24: synthesis of Compound 280
Step 1: synthesis of iridium dimer:
Figure BDA0003001663800000363
intermediate 46(0.15g, 0.526mmol) was dissolved in 9mL 2-ethoxyethanol and 3mL water at room temperature, and IrCl was added3·3H2O (62mg, 0.175mmol), heated to 160 ℃ in an autoclave, refluxed at this temperature for 24 hours, and cooled to room temperature. Filtering, washing the solid with ethanol until the washing liquid is colorless, and filtering to obtainTo red solid iridium dimer, which was used directly in the next reaction without purification.
Step 2: synthesis of compound 280:
Figure BDA0003001663800000364
the iridium dimer (0.25g, 0.157mmol) obtained in the previous step was charged to a 100mL round bottom flask, and K was added2CO3(217mg, 1.57mmol) and 3, 7-diethyl-3-methylnonane-4, 6-dione (142mg, 0.629mmol), 5mL of 2-ethoxyethanol and 5mL of DCM are added, the mixture is purged three times at room temperature, the mixture is heated to 40 ℃ and stirred for 24 hours under nitrogen. DCM was removed in vacuo, the solid was filtered through celite, the solid was washed with ethanol until the wash was colorless, and the ethanol was removed by suction filtration. The red solid on the celite was dissolved in 200mL of dichloromethane under vacuum filtration, 20mL of ethanol was added, dichloromethane was removed under vacuum, the solid precipitated, and the red solid compound 280(195mg, 0.20mmol, 63.7% yield) was filtered. The structure of the compound was confirmed by LC-MS to be the target product, molecular weight 986.3.
Synthetic example 25: comprising a ligand La1931Synthesis of the compound of (1)
Step 1: synthesis of intermediate 48
Figure BDA0003001663800000371
Intermediate 12(1.63g, 7.0mmol), intermediate 47(3.9g, 7.4mmol), Pd (PPh)3)4A mixture of (0.4g, 0.35mmol), sodium carbonate (1.11g, 10.5mmol) and 1, 4-dioxane/water (28mL/7mL) was heated to reflux under nitrogen overnight and cooled to room temperature after TLC indicated completion of the reaction. Water was added to the reaction, EA was used to extract the organic phase, which was dried, filtered and the solvent removed by rotary evaporation to give intermediate 48(3.2g, 76% yield).
Step 2: synthesis of intermediate 49
Figure BDA0003001663800000372
Intermediate 48(3.2g, 5.33mmol) was dissolved in 15mL of ethanol, then 15mL of HCl (2N) was slowly added to the reaction system, followed by heating to reflux, reaction for 2h, cooling to room temperature after TLC showed completion of the reaction, neutralized to neutral by addition of sodium bicarbonate solution, filtered to give crude solid, which was purified by column chromatography to give intermediate 49(2.65g, yield 94.5%).
And 3, step 3: synthesis of intermediate 50
Figure BDA0003001663800000373
Intermediate 49(2.65g, 5.0mmol), cuprous bromide (72mg, 0.5mmol), 2,2,6, 6-tetramethylheptanedione (0.74g, 4.0mmol), cesium carbonate (4.07g, 12.5mmol) and DMF (50mL) were heated to 135 ℃ under nitrogen blanket for reaction overnight, and cooled to room temperature after TLC indicated completion of the reaction. Water was added thereto until a large amount of yellow solid precipitated in the solution, which was filtered, washed several times with water and then dried by suction to give intermediate 50(2.26g, yield 92.4%) as a yellow solid.
And 4, step 4: synthesis of intermediate 51
Figure BDA0003001663800000381
Intermediate 50(2.26g, 4.62mmol), neopentyl boronic acid (1.07g, 9.23mmol), Pd2(dba)3(106mg,0.12mmol),Sphos(190mg,0.46mmol),K3PO4.3H2O (3.69g, 13.9mmol) and 30mL of toluene are mixed, the system is vacuumized, nitrogen is exchanged for three times, the mixture is heated to reflux and reacted overnight, TLC detection is carried out until the reaction is completed, the mixture is cooled to room temperature, solvent is removed by rotary evaporation to obtain a crude product, and the crude product is purified by column chromatography to obtain an intermediate 51(1.8g, yield 74%). The structure of this intermediate was confirmed by LC-MS as the target structure, molecular weight 525.3.
Starting from intermediate 51, the person skilled in the art refers to the methods of the prior art orThe method according to synthesis examples 1 to 24 was followed to obtain ligands L of the present inventiona1931The compound of (1).
It will be appreciated by those skilled in the art that the above preparation method is only an illustrative example, and that those skilled in the art can modify it to obtain other structures of the compounds of the present invention.
Device embodiments
Device example 1
First, a glass substrate, having an Indium Tin Oxide (ITO) anode 120nm thick, was cleaned and then treated with oxygen plasma and UV ozone. After treatment, the substrate was dried in a glove box to remove moisture. The substrate is then mounted on a substrate holder and loaded into a vacuum chamber. The organic layer specified below was at a vacuum of about 10-8In the case of torr, the evaporation was carried out on the ITO anode in turn by thermal vacuum evaporation at a rate of 0.2-2 a/s. Compound HI is used as Hole Injection Layer (HIL) with thickness
Figure BDA0003001663800000382
Compound HT as Hole Transport Layer (HTL), thickness
Figure BDA0003001663800000383
Compound EB1 was used as an Electron Blocking Layer (EBL), thickness
Figure BDA0003001663800000384
Then, the compound 81 of the present invention is doped in the host compound RH to be used as a light emitting layer (EML, 2:98) in thickness
Figure BDA0003001663800000385
Compound HB as Hole Blocking Layer (HBL), thickness
Figure BDA0003001663800000386
On HBL, a mixture of compound ET and 8-hydroxyquinoline-lithium (Liq) is deposited as an Electron Transport Layer (ETL) in thickness
Figure BDA0003001663800000387
Finally, depositingLiq with a thickness of 1nm was used as an electron injection layer, and 120nm of Al was deposited as a cathode. The device was then transferred back to the glove box and encapsulated with a glass lid and moisture absorber to complete the device.
Device example 2
Device example 2 was prepared in the same manner as in device example 1 except that the compound of the present invention 81 was replaced with the compound of the present invention 83 in the light emitting layer (EML).
Device example 3
Device example 3 was prepared in the same manner as in device example 1 except that the compound of the present invention 81 was replaced with the compound of the present invention 64 in the light-emitting layer (EML), the doping ratio of the compound of the present invention 64 to the compound RH was adjusted to 3:97, and the compound EB2 was replaced with the compound EB1 in the Electron Blocking Layer (EBL).
Device example 4
Device example 4 was prepared in the same manner as in device example 3 except that the compound of the present invention 93 was used instead of the compound of the present invention 64 in the light emitting layer (EML).
Device example 5
Device example 5 was prepared in the same manner as device example 3 except that the compound of the present invention 64 was replaced with the compound of the present invention 117 in the light emitting layer (EML).
Device example 6
Device example 6 was prepared in the same manner as device example 3 except that the compound of the present invention 64 was replaced with the compound of the present invention 116 in the light emitting layer (EML).
Device example 7
Device example 7 was prepared in the same manner as in device example 3 except that the compound 261 of the present invention was used instead of the compound 64 of the present invention in the light emitting layer (EML).
Device example 8
Device example 8 was prepared in the same manner as device example 3 except that the compound of the present invention 64 was replaced with the compound of the present invention 262 in the light emitting layer (EML).
Device example 9
Device example 9 was prepared in the same manner as device example 3 except that the compound 264 of the present invention was used in place of the compound 64 of the present invention in the light emitting layer (EML).
Device example 10
Device example 10 was prepared in the same manner as in device example 3 except that the compound 64 of the present invention was replaced with the compound 263 of the present invention in the light emitting layer (EML).
Device example 11
Device example 11 was prepared in the same manner as device example 3 except that the compound 64 of the present invention was replaced with the compound 266 of the present invention in the light emitting layer (EML).
Device example 12
Device example 12 was prepared in the same manner as device example 3 except that the compound 265 according to the present invention was used instead of the compound 64 according to the present invention in the light emitting layer (EML).
Device example 13
Device example 13 was prepared in the same manner as in device example 3 except that the present compound 267 was used in place of the present compound 64 in the light emitting layer (EML).
Device example 14
Device example 14 was prepared in the same manner as device example 3 except that the compound of the present invention 282 was used in place of the compound of the present invention 64 in the light emitting layer (EML).
Device example 15
Device example 15 was prepared in the same manner as device example 3 except that the present compound 64 was replaced with the present compound 273 in the light emitting layer (EML).
Device example 16
Device example 16 was prepared in the same manner as device example 3 except that the compound 294 of the present invention was used instead of the compound 64 of the present invention in the light emitting layer (EML).
Device example 17
Device example 17 was prepared in the same manner as device example 3 except that the compound 287 of the present invention was used instead of the compound 64 of the present invention in the light-emitting layer (EML).
Device example 18
Device example 18 was prepared in the same manner as in device example 3 except that the compound 291 according to the present invention was used instead of the compound 64 according to the present invention in the light emitting layer (EML).
Device example 19
Device example 19 was prepared in the same manner as device example 3 except that the compound 292 according to the present invention was used instead of the compound 64 according to the present invention in the light emitting layer (EML).
Device example 20
Device example 20 was prepared in the same manner as device example 3 except that the compound 293 of the present invention was used instead of the compound 64 of the present invention in the light emitting layer (EML).
Device example 21
Device example 21 was prepared in the same manner as in device example 3 except that the compound of the present invention 64 was replaced with the compound of the present invention 295 in the light emitting layer (EML).
Device comparative example 1
Device comparative example 1 was prepared in the same manner as in device example 1 except that the compound RD of the present invention was used in place of the compound 81 in the light emitting layer (EML).
Device comparative example 2
Device comparative example 2 was prepared in the same manner as in device example 3 except that the compound RD of the present invention was used in place of the compound 64 in the light emitting layer (EML).
The partial layer structure and thickness of the device are shown in the table below. Wherein more than one of the materials used is obtained by doping different compounds in the recited weight ratios.
TABLE 1 partial device structures of device examples and comparative examples
Figure BDA0003001663800000401
Figure BDA0003001663800000411
Figure BDA0003001663800000421
The structure of the materials used in the device is as follows:
Figure BDA0003001663800000422
Figure BDA0003001663800000431
Figure BDA0003001663800000441
Figure BDA0003001663800000451
the IVL and lifetime characteristics of the devices were measured at different current densities and voltages. Table 2 shows the results at 15mA/cm2CIE data, driving voltage (V), maximum emission wavelength (λ max), full width at half maximum (FWHM), and External Quantum Efficiency (EQE) of device example 1, device example 2, and device comparative example 1 measured at constant current, and at 80mA/cm2Lifetime at constant current (LT 97).
TABLE 2 device data
Figure BDA0003001663800000461
Discussion:
as is clear from the data shown in Table 2, the half-widths of the comparative example 1 and examples 1 and 2 were around 30nm, which was very striking. However, the maximum emission wavelength of comparative example 1 was 566nm, and in examples 1 and 2, the emission wavelength was shifted to a large red range from 606nm to 620nm by designing the molecular structure of the luminescent dopantThe requirement for different bands of red emission is satisfied. At 15mA/cm2At constant current, regardless of the voltage and the data of external quantum efficiency, example 1 and example 2 both outperformed comparative example 1, and in particular, the external quantum efficiency of example 2 was 36% higher than that of comparative example 1. According to comparative example 1 and examples 1 and 2 at 80mA/cm2The life data of LT97 under constant current were 2 hours for comparative example 1, 30 hours for example 1 and 105 hours for example 2, and it was found that the compounds disclosed in the present invention can greatly improve the device life in the electroluminescent device. From the above data analysis, it can be seen that the embodiments can effectively adjust the emission wavelength to meet the requirement of red light emission, reduce the voltage, improve the EQE, and most importantly, greatly improve the lifetime, thereby providing excellent performance, while maintaining a very narrow half-peak width.
Table 3 shows the results at 15mA/cm2CIE data, driving voltage (V), maximum emission wavelength (λ max), full width at half maximum (FWHM), and lifetime (LT97) of device example 3 measured at constant current.
TABLE 3 device data
Figure BDA0003001663800000462
Discussion:
as can be seen from the data shown in Table 3, by adjusting the molecular structure, the emission wavelength of example 3 was 633nm, in the deep red region, at 15mA/cm2The half-peak width of example 3 was also very narrow at 39nm and the driving voltage was relatively low at a constant current of 3.78V.
Table 4 shows the results at 15mA/cm2CIE data, drive voltage (V), and maximum emission wavelength (. lamda.) of comparative device example 2 and device examples 4 to 21 measured at constant currentmax) Full width at half maximum (FWHM) and External Quantum Efficiency (EQE), and at 80mA/cm2Lifetime at constant current (LT 97).
TABLE 4 device data
Figure BDA0003001663800000463
Figure BDA0003001663800000471
Discussion:
it can also be found from the device data in table 4 that in examples 4 to 13, the compound of the present invention successfully achieves a large red shift of the maximum emission wavelength of the device when used as a dopant of the light emitting layer, the emission wavelength is between 614nm and 623nm, and the requirement for different bands of red emission is met, while the maximum emission wavelength of comparative example 2 using the comparative compound RD is only 566nm, which completely fails to meet the requirement for the emission color of the red light device. Furthermore, at 15mA/cm2Although the half-peak widths and voltages of examples 4 to 13 were substantially equal to or slightly less than those of comparative example 2 at a constant current, it should be understood that the half-peak widths of examples 4 to 13 less than 36nm are still at a very high level in the industry, while the voltages of examples 4 to 13 are at a relatively low level in the industry, and the data of external quantum efficiencies of examples 4 to 13 are all further improved at a very high level relative to comparative example 2. Most importantly, the concentration of the compounds in examples 4-13 is 80mA/cm2The LT97 lifetime data at constant current were all improved to a very large extent (at least approximately 20 times, and at most approximately 50 times) relative to comparative example 2 (lifetime under this condition was only 3 hours, and completely failed to meet the requirements). The above comparisons again demonstrate the very excellent properties of the disclosed compounds.
It can also be found from the device data in table 4 that in examples 14 to 21, the compound of the present invention successfully achieves a large red shift of the maximum emission wavelength of the device when used as a dopant of the light emitting layer, the emission wavelength is between 607nm and 625nm, and the requirement for different wavelength bands of red emission is met, while the maximum emission wavelength of comparative example 2 using the comparative compound RD is only 566nm, which completely fails to meet the requirement for the emission color of the red device. Furthermore, at 15mA/cm2At a constant current, althoughThe half-peak widths and voltages of examples 14 to 21 were almost equal to or slightly insufficient compared to those of comparative example 2, but it should be understood that the half-peak widths of examples 14 to 21 which were less than 34nm were still at a very high level in the industry, the voltages of examples 14 to 21 were also at a relatively low level in the industry, and the data of the external quantum efficiencies of examples 14 to 21 were all maintained at a level close to that of comparative example 2 or were improved even further from that of comparative example 2. Most importantly, in examples 14 to 21, the concentration of the compound was 80mA/cm2The LT97 lifetime data at constant current were all improved by a very large amount (9 times minimum, 50 times maximum) compared to comparative example 2 (lifetime under this condition was only 3 hours, and completely failed to meet the requirements). The above comparisons again demonstrate the very excellent properties of the disclosed compounds.
Device example 22
Device example 22 was prepared in the same manner as in device example 3 except that the compound 280 according to the present invention was used in place of the compound 64 according to the present invention and the compound RH2 was used in place of the compound RH in the light-emitting layer (EML).
Device example 23
Device example 23 was prepared in the same manner as device example 22 except that the weight ratio of the compound 280 of the present invention to the host compound RH2 was adjusted to 2:98 in the light emitting layer (EML).
The partial layer structure and thickness of the device are shown in the table below. Wherein more than one of the materials used is obtained by doping different compounds in the recited weight ratios.
Table 5 partial device structures of device examples 22 and 23
Figure BDA0003001663800000472
Figure BDA0003001663800000481
The structure of the new materials used in the device is as follows:
Figure BDA0003001663800000482
the IVL and lifetime characteristics of the devices were measured at different current densities and voltages. Table 6 shows the results at 15mA/cm2CIE data, drive voltage (V), maximum emission wavelength (λ max), full width at half maximum (FWHM), and External Quantum Efficiency (EQE) of device examples 22 and 23 measured at constant current, and at 80mA/cm2Lifetime at constant current (LT 97).
TABLE 6 device data
Figure BDA0003001663800000483
As can be seen from the data in Table 6, when the compound of the present invention is used as a light emitting dopant in a device, the maximum emission wavelength of the device reaches 625nm, which satisfies the requirement of red light emission; meanwhile, the half-peak widths of examples 22 and 23 are both less than 30nm, which reaches a very striking level and can realize very saturated luminescence; in addition, the voltage of examples 22 and 23 is less than 3.5V, which is a very low voltage, and the external quantum efficiency is more than 20%, which is a relatively high device efficiency; more importantly, examples 22, 23 also had very long device lifetimes. The above data again demonstrate the very excellent properties of the disclosed compounds.
In conclusion, the disclosed compounds can effectively adjust the emission wavelength to meet the requirement of red light emission, reduce the voltage or maintain a low voltage level, improve the EQE, and most importantly, greatly improve the lifetime, in addition to maintaining a very narrow half-peak width, thereby providing excellent performance.
According to our research on the red light emitting material of the OLED, in the structure of the formula I, when the substituent R is not a hydrogen atom, the emission spectrum of the material can be well adjusted, and the external quantum efficiency of the material is improved:
Figure BDA0003001663800000491
however, according to our repeated studies, ligands having the formula di-structure cannot be successfully complexed with metals to form metal complexes:
Figure BDA0003001663800000492
unexpectedly, through the structural design, the substituent R in the formula I is designed to be a part in a merging ring, on one hand, a ligand with a corresponding structure, such as the formula 1 disclosed by the invention, can successfully perform a complex reaction with a metal to form a metal complex, and on the other hand, the device research result of related compounds shows that the metal complex with the structure disclosed by the invention has excellent device performance when being used as a luminescent material in an electroluminescent device, can effectively adjust the emission wavelength to meet the red light emission requirement, obtains a very narrow half-peak width, reduces or keeps low voltage, improves EQE, and most importantly, can greatly improve the service life, and the results further highlight the uniqueness and importance of the invention.
It should be understood that the various embodiments described herein are illustrative only and are not intended to limit the scope of the invention. Thus, the invention as claimed may include variations from the specific embodiments and preferred embodiments described herein, as will be apparent to those skilled in the art. Many of the materials and structures described herein may be substituted with other materials and structures without departing from the spirit of the present invention. It should be understood that various theories as to why the invention works are not intended to be limiting.

Claims (24)

1. A metal complex comprising a ligand La,LaHas a structure represented by formula 1:
Figure FDA0003001663790000011
wherein, ring A and ring B are each independently selected from five-membered unsaturated carbocyclic ring, aromatic ring with 6-30 carbon atoms or heteroaromatic ring with 3-30 carbon atoms;
Rithe same or different at each occurrence represents mono-, poly-, or no substitution; riiThe same or different at each occurrence represents mono-, poly-, or no substitution;
y is selected from SiRyRy,GeRyRy,NRy,PRyO, S or Se;
when two R are simultaneously presentyWhen two R are presentyMay be the same or different;
X1-X2selected from CR, identically or differently at each occurrencexOr N;
R、Ri、Rii、Rxand RyEach occurrence, identically or differently, is selected from the group consisting of: hydrogen, deuterium, halogen, substituted or unsubstituted alkyl groups having 1 to 20 carbon atoms, substituted or unsubstituted cycloalkyl groups having 3 to 20 ring carbon atoms, substituted or unsubstituted heteroalkyl groups having 1 to 20 carbon atoms, substituted or unsubstituted aralkyl groups having 7 to 30 carbon atoms, substituted or unsubstituted alkoxy groups having 1 to 20 carbon atoms, substituted or unsubstituted aryloxy groups having 6 to 30 carbon atoms, substituted or unsubstituted alkenyl groups having 2 to 20 carbon atoms, substituted or unsubstituted aryl groups having 6 to 30 carbon atoms, substituted or unsubstituted heteroaryl groups having 3 to 30 carbon atoms, substituted or unsubstituted alkylsilyl groups having 3 to 20 carbon atoms, substituted or unsubstituted arylsilyl groups having 6 to 20 carbon atoms, substituted or unsubstituted amine groups having 0-20 carbon atoms, acyl groups, carbonyl groups, carboxylic acid groups, ester groups, cyano groups, isocyano groups, mercapto groups, sulfinyl groups, sulfonyl groups, phosphino groups, and combinations thereof;
adjacent substituents Ri、Rx、RyR and RiiCan optionally be linked to form a ring;
the metal is selected from metals having a relative atomic mass greater than 40.
2. The metal complex of claim 1, wherein ring a and/or ring B are each independently selected from a five-membered unsaturated carbocyclic ring, an aromatic ring having 6 to 18 carbon atoms, or a heteroaromatic ring having 3 to 18 carbon atoms;
preferably, ring a and/or ring B are each independently selected from a five-membered unsaturated carbocyclic ring, an aromatic ring having 6 to 10 carbon atoms, or a heteroaromatic ring having 3 to 10 carbon atoms.
3. The metal complex of claim 1 or 2, wherein the LaA structure selected from the group consisting of structures represented by any one of formulas 2 to 19 and 22 to 23:
Figure FDA0003001663790000012
Figure FDA0003001663790000021
wherein,
in the formulae 2-19 and 22-23, X1-X2Selected from CR, identically or differently at each occurrencexOr N; x3-X7Selected from CR, identically or differently at each occurrenceiOr N; a. the1-A6Is selected, identically or differently on each occurrence, from CRiiOr N;
z is selected, identically or differently on each occurrence, from CRiiiRiii,SiRiiiRiii,PRiiiO, S or NRiii(ii) a When two R are simultaneously presentiiiWhen two R are presentiiiThe same or different;
y is selected from SiRyRy,NRy,PRyO, S or Se; when two R are simultaneously presentyWhen two R are presentyThe same or different;
R,Rx,Ry,Ri,Riiand RiiiIdentical or different at each occurrenceIs selected from the group consisting of: hydrogen, deuterium, halogen, substituted or unsubstituted alkyl groups having 1 to 20 carbon atoms, substituted or unsubstituted cycloalkyl groups having 3 to 20 ring carbon atoms, substituted or unsubstituted heteroalkyl groups having 1 to 20 carbon atoms, substituted or unsubstituted aralkyl groups having 7 to 30 carbon atoms, substituted or unsubstituted alkoxy groups having 1 to 20 carbon atoms, substituted or unsubstituted aryloxy groups having 6 to 30 carbon atoms, substituted or unsubstituted alkenyl groups having 2 to 20 carbon atoms, substituted or unsubstituted aryl groups having 6 to 30 carbon atoms, substituted or unsubstituted heteroaryl groups having 3 to 30 carbon atoms, substituted or unsubstituted alkylsilyl groups having 3 to 20 carbon atoms, substituted or unsubstituted arylsilyl groups having 6 to 20 carbon atoms, substituted or unsubstituted amine groups having 0-20 carbon atoms, acyl groups, carbonyl groups, carboxylic acid groups, ester groups, cyano groups, isocyano groups, mercapto groups, sulfinyl groups, sulfonyl groups, phosphino groups, and combinations thereof;
adjacent substituents R, Rx,Ry,Ri,RiiAnd RiiiCan optionally be linked to form a ring;
preferably, LaSelected from the group consisting of the structures represented by formula 2, formula 9, formula 11, and formula 12;
more preferably, LaSelected from the structures represented by formula 2.
4. The metal complex as claimed in claim 3, wherein, in the formulae 2 to 19 and 22 to 23, X1-XnAnd/or A1-AmAt least one of them is selected from N, XnCorresponding to the X1-X7The largest number among the groups represented by any of formulae 2 to 19 and 22 to 23, wherein A ismCorresponds to the A1-A6The largest sequence number among any one of the formulae 2 to 19 and 22 to 23;
preferably, in formula 2-formula 19 and formula 22-formula 23, X1-XnAt least one of them is selected from N, XnCorresponding to the X1-X7The largest sequence number among any one of the formulae 2 to 19 and 22 to 23;
more preferably, X2Is N.
5. The metal complex as claimed in claim 3, wherein, in the formulae 2 to 19 and 22 to 23, X1-X2Each independently selected from CRx;X3-X7Each independently selected from CRi;A1-A6Each independently selected from CRii(ii) a Adjacent substituents Rx、Ri、RiiCan optionally be linked to form a ring;
preferably, said R isx、Ri、RiiEach occurrence, the same or different, is selected from the group consisting of: hydrogen, deuterium, halogen, substituted or unsubstituted alkyl groups having 1 to 20 carbon atoms, substituted or unsubstituted cycloalkyl groups having 3 to 20 ring carbon atoms, substituted or unsubstituted aryl groups having 6 to 30 carbon atoms, substituted or unsubstituted heteroaryl groups having 3 to 30 carbon atoms, substituted or unsubstituted alkylsilyl groups having 3 to 20 carbon atoms, substituted or unsubstituted arylsilyl groups having 6 to 20 carbon atoms, cyano groups, and combinations thereof;
more preferably, said Rx、Ri、RiiAt least two or three of which, on each occurrence, are selected, identically or differently, from the group consisting of: deuterium, halogen, substituted or unsubstituted alkyl groups having 1 to 20 carbon atoms, substituted or unsubstituted cycloalkyl groups having 3 to 20 ring carbon atoms, substituted or unsubstituted aryl groups having 6 to 30 carbon atoms, substituted or unsubstituted heteroaryl groups having 3 to 30 carbon atoms, substituted or unsubstituted alkylsilyl groups having 3 to 20 carbon atoms, substituted or unsubstituted arylsilyl groups having 6 to 20 carbon atoms, cyano groups, and combinations thereof.
6. The metal complex compound according to any one of claims 3 to 5, wherein, in formulae 2 to 11 and 22 to 23, X is4And/or X5Selected from the group consisting of CRiIn the formula 12-formula 19, X3Selected from the group consisting of CRi
And said R isiSelected from hydrogen, identically or differently on each occurrence,deuterium, halogen, substituted or unsubstituted alkyl having 1 to 20 carbon atoms, substituted or unsubstituted cycloalkyl having 3 to 20 ring carbon atoms, substituted or unsubstituted aryl having 6 to 30 carbon atoms, substituted or unsubstituted heteroaryl having 3 to 30 carbon atoms, substituted or unsubstituted alkylsilyl having 3 to 20 carbon atoms, substituted or unsubstituted arylsilyl having 6 to 20 carbon atoms, cyano, or a combination thereof;
preferably, said R isiEach occurrence, the same or different, is selected from the group consisting of: hydrogen, deuterium, fluoro, methyl, ethyl, isopropyl, isobutyl, tert-butyl, neopentyl, cyclopentyl, cyclopentylmethyl, cyclohexyl, norbornyl, adamantyl, trimethylsilyl, isopropyldimethylsilyl, phenyldimethylsilyl, trifluoromethyl, cyano, phenyl, and combinations thereof.
7. The metal complex according to any one of claims 3 to 6, wherein, in formulae 2 to 19 and 22 to 23, R is selected from hydrogen, deuterium, halogen, substituted or unsubstituted alkyl group having 1 to 20 carbon atoms, substituted or unsubstituted cycloalkyl group having 3 to 20 ring carbon atoms, substituted or unsubstituted aryl group having 6 to 30 carbon atoms, substituted or unsubstituted heteroaryl group having 3 to 30 carbon atoms, substituted or unsubstituted alkylsilyl group having 3 to 20 carbon atoms, substituted or unsubstituted arylsilyl group having 6 to 20 carbon atoms, or a combination thereof;
preferably, said R is selected from hydrogen, deuterium, fluorine, methyl, ethyl, isopropyl, isobutyl, tert-butyl, cyclopentyl, cyclopentylmethyl, cyclohexyl, neopentyl, deuterated methyl, deuterated ethyl, deuterated isopropyl, deuterated isobutyl, deuterated tert-butyl, deuterated cyclopentyl, deuterated cyclopentylmethyl, deuterated cyclohexyl, deuterated neopentyl, trimethylsilyl, or a combination thereof.
8. The metal complex compound according to any one of claims 3 to 7, wherein, in formula 2-formula 19 and formula 22-formula 23, Y is selected from O or S; preferably, Y is O.
9. The metal complex compound according to any one of claims 3 to 8, wherein, in the formulae 2 to 19 and 22 to 23, X is1And X2Each independently selected from CRx
Preferably, said R isxEach occurrence is the same or different and is selected from the group consisting of hydrogen, deuterium, halogen, substituted or unsubstituted alkyl groups having 1 to 20 carbon atoms, substituted or unsubstituted cycloalkyl groups having 3 to 20 ring carbon atoms, substituted or unsubstituted aryl groups having 6 to 30 carbon atoms, substituted or unsubstituted heteroaryl groups having 3 to 30 carbon atoms, substituted or unsubstituted alkylsilyl groups having 3 to 20 carbon atoms, substituted or unsubstituted arylsilyl groups having 6 to 20 carbon atoms, or combinations thereof.
10. The metal complex compound according to any one of claims 3 to 8, wherein, in the formulae 2 to 19 and 22 to 23, X is1Selected from the group consisting of CRx,X2Is N;
preferably, said R isxSelected from the group consisting of hydrogen, deuterium, halogen, substituted or unsubstituted alkyl groups having 1 to 20 carbon atoms, substituted or unsubstituted cycloalkyl groups having 3 to 20 ring carbon atoms, substituted or unsubstituted aryl groups having 6 to 30 carbon atoms, substituted or unsubstituted heteroaryl groups having 3 to 30 carbon atoms, substituted or unsubstituted alkylsilyl groups having 3 to 20 carbon atoms, substituted or unsubstituted arylsilyl groups having 6 to 20 carbon atoms, or combinations thereof.
11. The metal complex of any one of claims 1 to 10, wherein the ligand LaHas a structure represented by formula 20 or formula 21:
Figure FDA0003001663790000041
wherein, in the formulae 20 and 21,
y is selected from O or S;
Rx1、Rx2、Ri1、Ri2、Ri3、Rii1、Rii2、Rii3、Rii4each occurrence, the same or different, is selected from the group consisting of: hydrogen, deuterium, halogen, substituted or unsubstituted alkyl groups having 1 to 20 carbon atoms, substituted or unsubstituted cycloalkyl groups having 3 to 20 ring carbon atoms, substituted or unsubstituted aryl groups having 6 to 30 carbon atoms, substituted or unsubstituted heteroaryl groups having 3 to 30 carbon atoms, substituted or unsubstituted alkylsilyl groups having 3 to 20 carbon atoms, substituted or unsubstituted arylsilyl groups having 6 to 20 carbon atoms, and combinations thereof;
r is selected, identically or differently on each occurrence, from the group consisting of: hydrogen, deuterium, halogen, substituted or unsubstituted alkyl groups having 1 to 20 carbon atoms, substituted or unsubstituted cycloalkyl groups having 3 to 20 ring carbon atoms, substituted or unsubstituted aryl groups having 6 to 30 carbon atoms, substituted or unsubstituted heteroaryl groups having 3 to 30 carbon atoms, substituted or unsubstituted alkylsilyl groups having 3 to 20 carbon atoms, substituted or unsubstituted arylsilyl groups having 6 to 20 carbon atoms, substituted or unsubstituted amine groups having 0 to 20 carbon atoms, and combinations thereof;
preferably, Rx1、Rx2、Ri1、Ri2、Ri3Neutralization/or Rii1、Rii2、Rii3、Rii4At least one or two of which, on each occurrence, are the same or different, are selected from deuterium, halogen, substituted or unsubstituted alkyl groups having 1 to 20 carbon atoms, substituted or unsubstituted cycloalkyl groups having 3 to 20 ring carbon atoms, substituted or unsubstituted aryl groups having 6 to 30 carbon atoms, substituted or unsubstituted heteroaryl groups having 3 to 30 carbon atoms, substituted or unsubstituted alkylsilyl groups having 3 to 20 carbon atoms, substituted or unsubstituted arylsilyl groups having 6 to 20 carbon atoms, or combinations thereof; r is selected from the group consisting of halogen, substituted or unsubstituted alkyl groups having from 1 to 20 carbon atoms, substituted or unsubstituted cycloalkyl groups having from 3 to 20 ring carbon atoms, substituted or unsubstituted aryl groups having from 6 to 30 carbon atoms, substituted or unsubstituted heteroaryl groups having from 3 to 30 carbon atoms, substituted or unsubstituted alkylsilyl groups having from 3 to 20 carbon atoms, substituted or unsubstituted alkyl groups having from 6 to 20 carbon atomsAn arylsilyl group, or a combination thereof;
more preferably, Rx1、Rx2、Ri1、Ri2、Ri3Neutralization/or Rii1、Rii2、Rii3、Rii4At least one or two of which are, identically or differently on each occurrence, selected from a substituted or unsubstituted alkyl group having 1 to 20 carbon atoms, a substituted or unsubstituted cycloalkyl group having 3 to 20 ring carbon atoms, a substituted or unsubstituted aryl group having 6 to 30 carbon atoms, a substituted or unsubstituted heteroaryl group having 3 to 30 carbon atoms, a substituted or unsubstituted alkylsilyl group having 3 to 20 carbon atoms, a substituted or unsubstituted arylsilyl group having 6 to 20 carbon atoms, or a combination thereof; r is selected from the group consisting of substituted or unsubstituted alkyl groups having 1 to 20 carbon atoms, substituted or unsubstituted cycloalkyl groups having 3 to 20 ring carbon atoms, substituted or unsubstituted aryl groups having 6 to 30 carbon atoms, substituted or unsubstituted heteroaryl groups having 3 to 30 carbon atoms, substituted or unsubstituted alkylsilyl groups having 3 to 20 carbon atoms, substituted or unsubstituted arylsilyl groups having 6 to 20 carbon atoms, or combinations thereof.
12. A metal complex according to claim 11, wherein Ri2Selected from the group consisting of: deuterium, halogen, substituted or unsubstituted alkyl groups having 1 to 20 carbon atoms, substituted or unsubstituted cycloalkyl groups having 3 to 20 ring carbon atoms, substituted or unsubstituted aryl groups having 6 to 30 carbon atoms, substituted or unsubstituted heteroaryl groups having 3 to 30 carbon atoms, substituted or unsubstituted alkylsilyl groups having 3 to 20 carbon atoms, substituted or unsubstituted arylsilyl groups having 6 to 20 carbon atoms, or combinations thereof; r is selected from the group consisting of halogen, substituted or unsubstituted alkyl groups having 1 to 20 carbon atoms, substituted or unsubstituted cycloalkyl groups having 3 to 20 ring carbon atoms, substituted or unsubstituted aryl groups having 6 to 30 carbon atoms, substituted or unsubstituted heteroaryl groups having 3 to 30 carbon atoms, substituted or unsubstituted alkylsilyl groups having 3 to 20 carbon atoms, substituted or unsubstituted arylsilyl groups having 6 to 20 carbon atoms, or combinations thereof; rii1、Rii2、Rii3、Rii4At least one or two of which, on each occurrence, are the same or different, are selected from deuterium, halogen, substituted or unsubstituted alkyl groups having 1 to 20 carbon atoms, substituted or unsubstituted cycloalkyl groups having 3 to 20 ring carbon atoms, substituted or unsubstituted aryl groups having 6 to 30 carbon atoms, substituted or unsubstituted heteroaryl groups having 3 to 30 carbon atoms, substituted or unsubstituted alkylsilyl groups having 3 to 20 carbon atoms, substituted or unsubstituted arylsilyl groups having 6 to 20 carbon atoms, or combinations thereof;
preferably, Ri2Selected from the group consisting of: a substituted or unsubstituted alkyl group having 1 to 20 carbon atoms, a substituted or unsubstituted cycloalkyl group having 3 to 20 ring carbon atoms, a substituted or unsubstituted aryl group having 6 to 30 carbon atoms, a substituted or unsubstituted heteroaryl group having 3 to 30 carbon atoms, a substituted or unsubstituted alkylsilyl group having 3 to 20 carbon atoms, a substituted or unsubstituted arylsilyl group having 6 to 20 carbon atoms, or a combination thereof; r is selected from the group consisting of substituted or unsubstituted alkyl groups having 1 to 20 carbon atoms, substituted or unsubstituted cycloalkyl groups having 3 to 20 ring carbon atoms, substituted or unsubstituted aryl groups having 6 to 30 carbon atoms, substituted or unsubstituted heteroaryl groups having 3 to 30 carbon atoms, substituted or unsubstituted alkylsilyl groups having 3 to 20 carbon atoms, substituted or unsubstituted arylsilyl groups having 6 to 20 carbon atoms, or combinations thereof; r isii1、Rii2、Rii3、Rii4At least one or two of which are, identically or differently on each occurrence, selected from a substituted or unsubstituted alkyl group having 1 to 20 carbon atoms, a substituted or unsubstituted cycloalkyl group having 3 to 20 ring carbon atoms, a substituted or unsubstituted aryl group having 6 to 30 carbon atoms, a substituted or unsubstituted heteroaryl group having 3 to 30 carbon atoms, a substituted or unsubstituted alkylsilyl group having 3 to 20 carbon atoms, a substituted or unsubstituted arylsilyl group having 6 to 20 carbon atoms, or a combination thereof.
13. The metal complex as claimed in claim 11 or 12, wherein R is represented by formula 20 and formula 21x1、Rx2、Ri1、Ri2、Ri3、Rii1、Rii2、Rii3、Rii4Each occurrence of at least one of R, is selected, identically or differently, from the group consisting of: substituted or unsubstituted alkyl groups having 3 to 20 carbon atoms, substituted or unsubstituted cycloalkyl groups having 3 to 20 ring carbon atoms, substituted or unsubstituted alkylsilyl groups having 3 to 20 carbon atoms, and combinations thereof;
preferably, Rx1、Rx2、Ri1、Ri2、Ri3、Rii1、Rii2、Rii3、Rii4Each occurrence of at least one of R, is selected, identically or differently, from the group consisting of: substituted or unsubstituted alkyl groups having 3 to 10 carbon atoms, substituted or unsubstituted cycloalkyl groups having 3 to 10 ring carbon atoms, and combinations thereof.
14. A metal complex according to any one of claims 1 to 13, wherein LaEach occurrence, the same or different, is selected from the group consisting of:
Figure FDA0003001663790000051
Figure FDA0003001663790000061
Figure FDA0003001663790000071
Figure FDA0003001663790000081
Figure FDA0003001663790000091
Figure FDA0003001663790000101
Figure FDA0003001663790000111
Figure FDA0003001663790000121
Figure FDA0003001663790000131
Figure FDA0003001663790000141
Figure FDA0003001663790000151
Figure FDA0003001663790000161
Figure FDA0003001663790000171
Figure FDA0003001663790000181
Figure FDA0003001663790000191
Figure FDA0003001663790000201
Figure FDA0003001663790000211
Figure FDA0003001663790000221
Figure FDA0003001663790000231
Figure FDA0003001663790000241
Figure FDA0003001663790000251
Figure FDA0003001663790000261
Figure FDA0003001663790000271
Figure FDA0003001663790000281
Figure FDA0003001663790000291
Figure FDA0003001663790000301
Figure FDA0003001663790000311
Figure FDA0003001663790000321
Figure FDA0003001663790000331
Figure FDA0003001663790000341
Figure FDA0003001663790000351
Figure FDA0003001663790000361
Figure FDA0003001663790000371
Figure FDA0003001663790000381
Figure FDA0003001663790000391
Figure FDA0003001663790000401
Figure FDA0003001663790000411
Figure FDA0003001663790000421
Figure FDA0003001663790000431
Figure FDA0003001663790000441
Figure FDA0003001663790000451
Figure FDA0003001663790000461
Figure FDA0003001663790000471
Figure FDA0003001663790000481
Figure FDA0003001663790000491
Figure FDA0003001663790000501
Figure FDA0003001663790000511
Figure FDA0003001663790000521
Figure FDA0003001663790000531
Figure FDA0003001663790000541
Figure FDA0003001663790000551
Figure FDA0003001663790000561
Figure FDA0003001663790000571
Figure FDA0003001663790000581
Figure FDA0003001663790000591
Figure FDA0003001663790000601
wherein, in the above structure, TMS is trimethylsilyl;
wherein, optionally, the hydrogen in the above structure can be partially or fully substituted with deuterium.
15. The metal complex of any one of claims 1-14, wherein the metal complex has M (L)a)m(Lb)n(Lc)qThe structure of (1);
wherein the metal M is selected from metals having a relative atomic mass greater than 40; l isa、LbAnd LcA first ligand, a second ligand and a third ligand, respectively, of the complex; m is 1,2 or 3, n is 0, 1 or 2, q is 0, 1 or 2, M + n + q is equal to the oxidation state of the metal M; when m is greater than 1, a plurality of LaThe same or different; when n is 2, two LbThe same or different; when q is 2, two LcThe same or different;
La、Lband LcOptionally linked to form a multidentate ligand;
Lband LcEach occurrence, the same or different, is selected from the group consisting of:
Figure FDA0003001663790000611
wherein R isa、RbAnd RcThe same or different at each occurrence represents mono-, poly-, or no substitution;
Xbeach occurrence, the same or different, is selected from the group consisting of: o, S, Se, NRN1And CRC1RC2
XcAnd XdEach occurrence, the same or different, is selected from the group consisting of: o, S, Se and NRN2
Ra、Rb、Rc、RN1、RN2、RC1And RC2Each occurrence, the same or different, is selected from the group consisting of: hydrogen, deuterium, halogen, a substituted or unsubstituted alkyl group having 1 to 20 carbon atoms, a substituted or unsubstituted cycloalkyl group having 3 to 20 ring carbon atoms, a substituted or unsubstituted heteroalkyl group having 1 to 20 carbon atoms, a substituted or unsubstituted aralkyl group having 7 to 30 carbon atoms, a substituted or unsubstituted alkoxy group having 1 to 20 carbon atoms, a substituted or unsubstituted aryloxy group having 6 to 30 carbon atoms, a substituted or unsubstituted alkenyl group having 2 to 20 carbon atoms, a substituted or unsubstituted aryl group having 6 to 30 carbon atoms, a substituted or unsubstituted heteroaryl group having 3 to 30 carbon atoms, a substituted or unsubstituted alkylsilyl group having 3 to 20 carbon atoms, a substituted or unsubstituted arylsilyl group having 6 to 20 carbon atoms, substituted or unsubstituted amine groups having 0-20 carbon atoms, acyl groups, carbonyl groups, carboxylic acid groups, ester groups, cyano groups, isocyano groups, mercapto groups, sulfinyl groups, sulfonyl groups, phosphino groups, and combinations thereof;
wherein the adjacent substituents Ra、Rb、Rc、RN1、RN2、RC1And RC2Can optionally be linked to form a ring.
16. The metal complex of claim 15, wherein the metal M is selected from Ir, Rh, Re, Os, Pt, Au or Cu; preferably, the metal M is selected from Ir, Pt or Os; more preferably, the metal M is Ir.
17. A metal complex as claimed in claim 15 or 16 wherein LbEach occurrence, identically or differently, is selected from the following structures:
Figure FDA0003001663790000612
wherein R is1–R7Each occurrence, the same or different, is selected from the group consisting of: hydrogen, deuterium, halogen, a substituted or unsubstituted alkyl group having 1 to 20 carbon atoms, a substituted or unsubstituted cycloalkyl group having 3 to 20 ring carbon atoms, a substituted or unsubstituted heteroalkyl group having 1 to 20 carbon atoms, a substituted or unsubstituted aralkyl group having 7 to 30 carbon atoms, a substituted or unsubstituted alkoxy group having 1 to 20 carbon atoms, a substituted or unsubstituted aryloxy group having 6 to 30 carbon atoms, a substituted or unsubstituted alkenyl group having 2 to 20 carbon atoms, a substituted or unsubstituted aryl group having 6 to 30 carbon atoms, a substituted or unsubstituted heteroaryl group having 3 to 30 carbon atoms, a substituted or unsubstituted alkylsilyl group having 3 to 20 carbon atoms, a substituted or unsubstituted arylsilyl group having 6 to 20 carbon atoms, substituted or unsubstituted amine groups having 0-20 carbon atoms, acyl groups, carbonyl groups, carboxylic acid groups, ester groups, cyano groups, isocyano groups, mercapto groups, sulfinyl groups, sulfonyl groups, phosphino groups, and combinations thereof;
preferably, wherein R1-R3At least one or two of which are selected from substituted or unsubstituted alkyl groups having 1 to 20 carbon atoms, substituted or unsubstituted cycloalkyl groups having 3 to 20 ring carbon atoms, substituted or unsubstituted heteroalkyl groups having 1 to 20 carbon atoms, or combinations thereof; and/or R4-R6At least one of which is a substituted or unsubstituted alkyl group having 1 to 20 carbon atoms, a substituted or unsubstituted cycloalkyl group having 3 to 20 ring carbon atoms, a substituted or unsubstituted heteroalkyl group having 1 to 20 carbon atoms, or combinations thereof;
more preferably, wherein R1-R3At least two of which are selected from substituted or unsubstituted alkyl groups having 2 to 20 carbon atoms, substituted or unsubstituted cycloalkyl groups having 3 to 20 ring carbon atoms, substituted or unsubstituted heteroalkyl groups having 2 to 20 carbon atoms, or combinations thereof; and/or R4-R6At least two of them are selected from substituted or unsubstituted alkyl groups having 2 to 20 carbon atoms, substituted or unsubstituted alkyl groups having 3 to 20 ring carbon atomsSubstituted or unsubstituted heteroalkyl groups having 2-20 carbon atoms, or combinations thereof.
18. The metal complex of any one of claims 15-17, wherein LbEach occurrence, the same or different, is selected from the group consisting of:
Figure FDA0003001663790000621
Figure FDA0003001663790000631
Figure FDA0003001663790000641
Figure FDA0003001663790000651
Figure FDA0003001663790000661
Figure FDA0003001663790000671
Figure FDA0003001663790000681
wherein L iscEach occurrence, the same or different, is selected from the group consisting of:
Figure FDA0003001663790000682
Figure FDA0003001663790000691
Figure FDA0003001663790000701
Figure FDA0003001663790000711
Figure FDA0003001663790000721
Figure FDA0003001663790000731
19. the metal complex of claim 18, wherein the metal complex has Ir (L)a)2(Lb) Or Ir (L)a)2(Lc) Or Ir (L)a)(Lc)2The structure of (1);
wherein when the metal complex has Ir (L)a)2(Lb) In the structure of (1), LaEach occurrence being selected identically or differently from La1To La1931Any one or any two of the group consisting of, LbIs selected from the group consisting of Lb1To Lb322Any one of the group consisting of; when the metal complex has Ir (L)a)2(Lc) In the structure of (1), LaEach occurrence, identically or differently, of a group selected from La1To La1931Any one or any two of the group consisting of, LcIs selected from the group consisting of Lc1To Lc231Any one of the group consisting of; when the metal complex has Ir (L)a)(Lc)2In the structure of (1), LaIs selected from the group consisting of La1To La1931Any one of the group consisting of LcEach occurrence being selected identically or differently from Lc1To Lc231Any one or any two of the group consisting of;
preferably, wherein the metal complex is selected from the group consisting of compound 1 to compound 312;
wherein the compounds 1 to 200 and 261 to 312 have Ir (L)a)2(Lb) Wherein two L areaSame, LaAnd LbEach corresponding to a structure selected from those listed in the following table:
Figure FDA0003001663790000741
Figure FDA0003001663790000751
Figure FDA0003001663790000761
wherein compound 201 to compound 260 have Ir (L)a)2(Lb) Wherein two L areaDifferent, LaAnd LbEach corresponding to a structure selected from those listed in the following table:
Figure FDA0003001663790000762
Figure FDA0003001663790000771
20. an electroluminescent device, comprising:
an anode, a cathode, a anode and a cathode,
a cathode electrode, which is provided with a cathode,
and an organic layer disposed between the anode and the cathode, the organic layer comprising the metal complex of any one of claims 1-19.
21. The electroluminescent device of claim 20, wherein the organic layer is a light-emitting layer and the metal complex is a light-emitting material.
22. An electroluminescent device as claimed in claim 20 or 21 in which the electroluminescent device emits red or white light.
23. The electroluminescent device of claim 21, wherein said light-emitting layer further comprises at least one host material; preferably, the at least one host material comprises at least one chemical group selected from the group consisting of: benzene, pyridine, pyrimidine, triazine, carbazole, azacarbazole, indolocarbazole, dibenzothiophene, azadibenzothiophene, dibenzofuran, azadibenzofuran, dibenzoselenophene, triphenylene, azatriphenylene, fluorene, silafluorene, naphthalene, quinoline, isoquinoline, quinazoline, quinoxaline, phenanthrene, azaphenanthrene, and combinations thereof.
24. A combination of compounds comprising the metal complex of any one of claims 1-19.
CN202110348602.6A 2020-04-30 2021-04-01 Luminescent material with polycyclic ligand Pending CN114437134A (en)

Priority Applications (7)

Application Number Priority Date Filing Date Title
US17/241,836 US20220109118A1 (en) 2020-04-30 2021-04-27 Light-emitting material with a polycyclic ligand
DE102021110753.9A DE102021110753B4 (en) 2020-04-30 2021-04-27 Light-emitting material with a polycyclic ligand
JP2021076326A JP7278631B2 (en) 2020-04-30 2021-04-28 Emissive materials with polycyclic ligands
KR1020210055624A KR102652631B1 (en) 2020-04-30 2021-04-29 Light-emitting material with a polycyclic ligand
US17/979,546 US20230144101A1 (en) 2020-04-30 2022-11-02 Light-emitting material with a polycyclic ligand
JP2023072357A JP2023090828A (en) 2020-04-30 2023-04-26 Luminescent material having polycyclic ligand
KR1020240039587A KR20240041899A (en) 2020-04-30 2024-03-22 Light-emitting material with a polycyclic ligand

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
CN202010362117X 2020-04-30
CN202010362117 2020-04-30
CN2020112196047 2020-11-09
CN202011219604 2020-11-09

Publications (1)

Publication Number Publication Date
CN114437134A true CN114437134A (en) 2022-05-06

Family

ID=81362404

Family Applications (1)

Application Number Title Priority Date Filing Date
CN202110348602.6A Pending CN114437134A (en) 2020-04-30 2021-04-01 Luminescent material with polycyclic ligand

Country Status (1)

Country Link
CN (1) CN114437134A (en)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN114249738A (en) * 2020-06-05 2022-03-29 北京夏禾科技有限公司 Electroluminescent material and device
CN114478643A (en) * 2020-10-23 2022-05-13 乐金显示有限公司 Organometallic compound, organic light emitting diode and organic light emitting device having the same

Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2007254540A (en) * 2006-03-22 2007-10-04 Showa Denko Kk Polymer luminescent material, organoelectroluminescent element and display device
CN109956977A (en) * 2017-12-25 2019-07-02 北京夏禾科技有限公司 The metal complex of the ligand containing heterocyclic substituted, and electroluminescent device and compound formulas comprising the complex compound
CN110698518A (en) * 2019-11-08 2020-01-17 吉林奥来德光电材料股份有限公司 Organic phosphorus luminescent material and preparation method thereof
CN110790797A (en) * 2019-11-08 2020-02-14 吉林奥来德光电材料股份有限公司 Organic phosphorus luminescent material and preparation method and application thereof
CN110922429A (en) * 2018-09-20 2020-03-27 北京夏禾科技有限公司 Organic luminescent material containing novel auxiliary ligand

Patent Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2007254540A (en) * 2006-03-22 2007-10-04 Showa Denko Kk Polymer luminescent material, organoelectroluminescent element and display device
CN109956977A (en) * 2017-12-25 2019-07-02 北京夏禾科技有限公司 The metal complex of the ligand containing heterocyclic substituted, and electroluminescent device and compound formulas comprising the complex compound
CN110922429A (en) * 2018-09-20 2020-03-27 北京夏禾科技有限公司 Organic luminescent material containing novel auxiliary ligand
CN110698518A (en) * 2019-11-08 2020-01-17 吉林奥来德光电材料股份有限公司 Organic phosphorus luminescent material and preparation method thereof
CN110790797A (en) * 2019-11-08 2020-02-14 吉林奥来德光电材料股份有限公司 Organic phosphorus luminescent material and preparation method and application thereof

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN114249738A (en) * 2020-06-05 2022-03-29 北京夏禾科技有限公司 Electroluminescent material and device
CN114249738B (en) * 2020-06-05 2023-11-03 北京夏禾科技有限公司 Electroluminescent material and device
CN114478643A (en) * 2020-10-23 2022-05-13 乐金显示有限公司 Organometallic compound, organic light emitting diode and organic light emitting device having the same

Similar Documents

Publication Publication Date Title
KR102394907B1 (en) Organic luminescent materials containing novel ancillary ligands
CN109422770B (en) Boron-containing heterocyclic compounds for OLEDs, organic light emitting devices, and compound formulations comprising the same
CN111518139A (en) Organic luminescent material containing cyano-substituted ligand
KR20210138549A (en) Metal complex with fluorine substitution
KR102541507B1 (en) Organic luminescent material containing 6-silyl-substituted isoquinoline ligand
CN109956977A (en) The metal complex of the ligand containing heterocyclic substituted, and electroluminescent device and compound formulas comprising the complex compound
CN109651065B (en) Tetraortho-phenylene anthracene compounds
CN109467575B (en) Organic luminescent material containing fluorine auxiliary ligand
CN109721628B (en) Fluorenyl thienopyrimidine luminescent materials
KR102652631B1 (en) Light-emitting material with a polycyclic ligand
CN111909214A (en) Organic luminescent material containing 3-deuterium substituted isoquinoline ligand
CN114621199A (en) Organic electroluminescent material and device thereof
CN109575083A (en) The luminous organic material of the assistant ligand containing naphthenic base
CN114907412A (en) Organic electroluminescent material and device thereof
CN109796499B (en) Metal complexes of azabenzothiazoles containing nitrogen
CN111620853A (en) Organic electroluminescent material and device thereof
CN111018921A (en) Metal complex and electroluminescent device containing same
CN113278033A (en) Organic electroluminescent material and device
CN113816997A (en) Phosphorescent organic metal complex and application thereof
CN114907413A (en) Organic electroluminescent material and device thereof
CN114437134A (en) Luminescent material with polycyclic ligand
CN111635436A (en) Fluorine-containing substituted metal complex
CN114181235A (en) Polycyclic compounds and devices thereof
CN110054650B (en) Metal complexes comprising substituted pyridine ligands
CN113683643A (en) Organic luminescent material

Legal Events

Date Code Title Description
PB01 Publication
PB01 Publication
SE01 Entry into force of request for substantive examination
SE01 Entry into force of request for substantive examination